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ABSTRACT 
Spiromamakone A is a racemic natural product having a naphthyl acetal group on a 
spiro[4,4]nonadiene skeleton. Its total synthesis was achieved by double oxa-Michael addition of 
1,8-dihydroxynaphthalene to 2-(1-bromoalkylidene)-4-isopropoxy-4-cyclopentene-1,3-dione, which 
was prepared by palladium(II)-catalyzed ring expansion of 4-(1-alkynyl)-4-hydroxy-3-isopropoxy-2-
cyclobuten-1-one, and subsequent intramolecular aldol reaction. The synthesis using optically active 
intermediates enabled to identify the racemization step of spiromamakone A and revealed that 
spiromamakone A and spiropreussione A are identical; the latter has been reported as a 
constitutional isomer of the other. 
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Spiromamakone A (1)1 and spiropreussione A (2)2 were isolated from endophytic fungi by the 
groups of Munro and Guo, respectively. These natural products belong to the spirobisnaphthalene 
class of compounds, characterized by two naphthalene-derived C10 units bridged by a spiroacetal 
linkage3; however, they have a unique spiro[4,4]nonadiene skeleton resulting from the loss of one 
carbon atom and the intramolecular aldol reaction during biosynthesis.4, 5 These compounds have a 
single stereogenic center on the A-rings, but they are isolated as a racemic mixture because of their 
aldol-adduct structure, which can undergo a reversible retro-aldol reaction. They exhibit cytotoxicity 
against cancer cell lines; in particular, spiromamakone A has an IC50 of 0.33 µM against the murine 
leukemia cell line P388, and spiropreussione A shows IC50 of 2.4 and 3.0 µM against the human 
ovarian carcinoma cell line A2780 and the liver carcinoma cell line BEL-704, respectively. As part 
of our ongoing research to find more potent anticancer agents,6 we recently achieved the syntheses 
of the proposed structure for spiropreussione A (2) as well as spiromamakone A benzo-analog 3 
(Figure 1).7, 8 The syntheses showed that analog 3 was as cytotoxic as spiromamakone A (1), and the 
proposed structure of 2 was incorrect. Here we report a total synthesis of spiromamakone A (1) 
based on the double oxa-Michael addition of 1,8-dihydroxynaphthalene (DHN) to 2-(1-
bromoalkylidene)-4-isopropoxy-4-cyclopentene-1,3-dione and the intramolecular aldol reaction. The 
study determined what makes 1 racemic, and the results allowed us to revise the structure of 
spiropreussione A (2), which turned out to be identical to spiromamakone A (1). 
 
Figure 1. Structures of spiromamakone A (1), spiropreussione A (2),7, 8 and spiromamakone A 
benzo-analog 3. 
The synthesis of spiromamakone A benzo-analog 3 was based on successive substitutions of the 
methylthio groups in α,α′-dioxoketene dithioacetal derived from 1,3-cyclopentanedione by 
arylmagnesium bromide and DHN.7 Therefore, to construct an A-ring with a double bond instead of 
a benzene ring via a substitution reaction, Grignard reagents other than arylmagnesium bromide 
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were tested.9 Although neither alkenyl- nor alkynylmagnesium bromides provided the desired 
products, the alkylmagnesium one underwent the substitution as effectively as the aryl one did. 
However, the following double oxa-Michael addition10 of DHN to the resulting sulfide or sulfoxide 
was unsuccessful because of either the low reactivity of the sulfide or the instability of the sulfoxide. 
Moreover, it would be difficult to investigate a racemization process of 1 in the synthetic route using 
a chiral auxiliary, i.e., a heteroatom at the β- or α-position of the alkylmetal species, because of its 
susceptibility to β-elimination or epimerization, respectively. 
We assumed that the stability of the Michael acceptor would be improved by substituting 4-
cyclopentene-1,3-dione for cyclopentane-1,3-dione owing to an increase in the strain of the transient 
dienolate generated by the nucleophilic addition prior to the elimination, although a protecting group 
is necessary to prevent undesired nucleophilic addition to the endo-olefin. Hence, we chose 7 as the 
Michael acceptor, in which the endo olefin is protected by an isopropoxy group and the leaving 
group, i.e., bromide, does not need to be oxidized (Scheme 1). The Michael acceptor can be 
synthesized by palladium(II)-catalyzed ring expansion11, 12 of propargyl alcohol 8 prepared by 
regioselective 1,2-addition of acetylide 10 to 3-isopropoxy-3-cyclobutene-1,2-dione 9.13 The use of 
optically active acetylide 10 would induce the diastereoselective intramolecular aldol reaction for 5 
after double oxa-Michael addition of DHN to 7. As an equivalent to aldehyde 10, we selected 
isopropylidene acetal 11,14 in which the terminal acetal can be transformed into aldehyde through 
successive hydrolysis and oxidative cleavage in the presence of periodic acid.15 The protection of the 
resulting aldol hydroxyl group and the following introduction of a double bond in the A-ring and 
reductive removal of the isopropoxy group from the B-ring can provide an optically active protected 
spiromamakone A. The synthetic route enabled us to identify the racemization step during or after 
the deprotection. 
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Scheme 1. Retrosynthesis of Spiromamakone A (1). 
 
 
The synthesis of spiromamakone A (1) began with the preparation of terminal alkyne 1114 and 3-
isopropoxy-3-cyclobutene-1,2-dione 9.13 Protected D-glyceraldehyde 12 (Scheme 2) was prepared 
from D-mannitol according to the well-known procedure16 and treated with propargylzinc bromide. 
Despite the several reports on the selective conversion of 12 into homopropargylic alcohol 13 using 
a propargylzinc reagent generated in situ,17–19 all of the reported reactions were not reproducible and 
formed both its diastereomer and isomeric allene in considerable amounts. We screened different 
conditions to determine the optimal combination to generate the organozinc reagent; the addition of 
a stoichiometric amount of lithium chloride and a catalytic amount of 1,2-dibromoethane and a 
reaction temperature of −78 °C were the most effective conditions for the highly diastereoselective 
propargylation of aldehyde 12 without formation of allene.20 Alcohol 13 was protected by a TBS 
group and used for the successive ethynylation of 9,13 which was obtained via a modified one-pot 
sequence consisting of the reduction of diisopropyl squarate 1413 with lithium tri-tert-
butoxyaluminum hydride and acid hydrolysis. 
Regioselective 1,2-addition of the lithium salt of 11 to 1,2-diketone 9 was followed by 
palladium(II)-catalyzed ring expansion11, 12 reaction after aqueous work-up. Although the ring 
expansion of the monosubstituted cyclobutene was much less clean than that of the 3,4-disubstituted 
one, a DABCO-promoted double oxa-Michael addition with excess of crude bromide in relation to 
DHN 6 resulted in naphthyl acetals 16a and 16b as an inseparable 1:1 diastereomeric mixture in 
moderate yield. Interestingly, successive hydrolysis and oxidative cleavage of terminal 
isopropylidene acetal 16a–b15 led to the formation of crude aldehydes 17a–b instead of aldol 
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products, which were successfully converted into methoxymethyl-protected aldols 18a–b as a 
separable 1:1 diastereomeric mixture under the general conditions for the protection of a hydroxyl 
group with a methoxymethyl group. NOESY spectra of diastereomers 18a and 18b suggested that 
trans-1,2-diols were formed during the intramolecular aldol reaction and that the diastereomers 
derived from spiro carbon C-5. Removal of TBS protecting groups from 18a and 18b resulted in the 
formation of alcohols 19a and 19b. The structure of 19a was determined by X-ray crystallography 
(Figure 2) to support the above prediction.21 Then, a double bond between C-2 and C-3 was 
introduced by anti-elimination through mesylation of the alcohol and subsequent DBU-promoted 
elimination. 
 
Scheme 2. Synthesis of the Isopropoxy Analog of Spiromamakone A. 
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Figure 2. X-ray crystal structure of alcohol 19a (ellipsoid contour at the 50% probability level). 
 
To get insights into the racemization of 1, the methoxymethyl group was removed from 
isopropoxy analog 20b. Although aldol 21b was obtained as a single diastereomer in the crude 
product, the purification on a silica gel formed an inseparable 1:1 diastereomeric mixture of 21b and 
21a (diastereomerically pure 21a was also obtained by acid hydrolysis of 20a; see Experimental 
Section). Moreover, diastereomerically pure 21b was reprotected by a methoxymethyl group to give 
a separable 1:1 diastereomeric mixture of 20a and 20b, both of which were racemic according to 
their specific rotation values. The results showed that the aldol/retro-aldol reaction took place during 
the treatment with silica gel and the methoxymethyl protection. On the basis of this observation, we 
assumed that parent natural product 1 would behave similarly. 
The final step was the reductive removal of the isopropoxy group from 20a–b. Lithium aluminum 
hydride can reduce 4-hydroxy or acetoxy-3-alkoxy-2-cyclopenten-1-one to 4-hydroxy-1-
cylopentanone,22, 23 which is transformed into 4-cyclopentene-1,3-dione by two-step oxidation 
through 1,3-cyclopentanedione. The reduction proceeds through formation of aluminate at C-4, 
intramolecular 1,4-addition of hydride, elimination of alkoxy group from C-3, and second 1,4-
reduction to give 4-hydroxycyclopentanone after hydrolytic work-up. To conduct such conversion, 
4-hydroxy-3-isopropoxy-2-cyclopenten-1-one 22a was prepared by regio- and stereoselective 1,2-
reduction of ketone 20a with potassium borohydride, and the stereochemistry of 22a was determined 
by NOESY spectra of its acetate 23a (Scheme 3). As expected, the treatment of 22a with lithium 
aluminum hydride in THF provided 3-hydroxy-cyclopentanone 24 in 54% yield along with 1,3-
cyclopentanediol 25. Dess–Martin oxidation of 24 and 25 gave 1,3-cyclopentanedione 26 in 89% 
and 93% yield, respectively (see also Scheme 4). Further oxidation of 26 with 
trimethylphenylammonium tribromide24 formed 4-cyclopentene-1,3-dione 27 along with 
spiromamakone A (1), and the latter could be obtained by cleavage of the methoxymethyl group 
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with in situ generated hydrogen bromide. Removal of the methoxymethyl group from 27 in acidic 
conditions successfully provided 1 in high yield. NMR spectral data of synthetic 1 in methanol-d4 
were in full agreement with those of natural spiromamakone A reported by Munro.1 As observed in 
21b (Scheme 2), the specific rotation value of crude 1 was lowered by purification with silica gel 
chromatography. In addition, the NMR spectra of the synthesized spiromamakone A in chloroform-d 
were completely identical to those recorded for spiropreussione A, whose proposed structure was 
proved incorrect by our previous study.8 Therefore, the revised structure of spiropreussione A should 
be spiromamakone A itself. Unfortunately, 3-hydroxy-4-cyclopenten-1-one 22b obtained by 
reduction of diastereomer 20b with sodium borohydride underwent not 1,4-reduction but 1,2-
reduction to give 2-hydroxy-4-cyclopenten-1-one 30 after acid hydrolysis. 
 
Scheme 3. Transformation of 20a into Spiromamakone A. 
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Although 20b can be reused after its conversion into a mixture of 20a and 20b through the above-
mentioned sequence, reducing agents other than lithium aluminum hydride were screened to 
transform both diastereomers 22a and 22b into the natural product (Scheme 4). Among the tested 
reagents, lithium borohydride in THF reduced 22a and 22b and gave 4-isopropoxy-1,3-
cyclopentanediol 32a and a diastereomeric mixture of 32b and 32b′ along with their analogs 25 and 
25′ without isopropoxy groups, and the latter can be converted to common 1,3-cyclopentanedione 26 
by Dess–Martin oxidation. Unlike lithium aluminum hydride, the reduction with lithium 
borohydride involves protonation of an enolate generated in situ by 1,4-reduction and 1,2-reduction 
prior to the elimination of isopropoxide, although it is unclear what could be the proton source in the 
aprotic solvent THF.25 Dess–Martin oxidation of diols 32a, 32b, and 32b′ and exposure of crude 
cyclopentane-1,3-diones 33a and 33b on silica gel for 4 h led to the formation of common 4-
cyclopentene-1,3-dione 27 in good yield through β-elimination of isopropanol. Thus, the reaction 
sequence using lithium borohydride can convert both diastereomers 22a and 22b to methoxymethyl-
protected spiromamakone A without the oxidation of cyclopentane-1,3-dione. 
 
Scheme 4. Transformation of 22a–b into MOM-Protected Spiromamakone A 27. 
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In summary, we achieved a total synthesis of spiromamakone A (1), in which the key naphthyl 
acetal was obtained by double oxa-Michael addition of 1,8-dihydroxynaphthalene to 2-(1-
bromoalkylidene)-4-isopropoxy-4-cyclopentene-1,3-dione. The reductive removal of the 4-
isopropoxy group in 4-cyclopentene-1,3-diones 20a–b was given by silica gel-promoted elimination 
of isopropanol from the saturated cyclopentane-1,3-diones 33a–b obtained by a reaction sequence 
involving regio- and stereoselective 1,2-reduction, successive lithium borohydride-promoted 1,4- 
and 1,2-reductions, and oxidation of cyclopentane-1,3-diols 32a–b. The optically active protected 
spiromamakone A readily underwent racemization during not the deprotection but the purification 
step on silica gel. In addition, we revealed that spiropreussione A, considered an isomer of 
spiromamakone A, was identical to spiromamakone A itself. A structure–activity relation study of 
the synthesized compounds and their derivatives is underway.  
 
EXPERIMENTAL SECTION 
General Techniques. All commercially available reagents and anhydrous solvents including 
dichloromethane, 1,2-dimethoxyethane, ethyl acetate, and tetrahydrofuran (THF) were purchased 
and used without further purification. Anhydrous acetonitrile was obtained by distillation from 
calcium hydride. Anhydrous diethyl ether was obtained by drying over molecular sieves 4A. 
Anhydrous toluene was obtained by distillation from sodium. All reactions were monitored by thin 
layer chromatography (TLC) performed on 0.25 mm silica gel glass plates (60 F254) using UV light 
and ethanolic p-anisaldehyde-sulfuric acid, ethanolic molybdatophosphoric acid, aqueous cerium 
sulfate-hexaammonium heptamolybdate-sulfuric acid, or aqueous potassium permanganate-
potassium carbonate-sodium hydroxide solutions as visualizing agents. Flash column 
chromatography was carried out with silica gel (spherical, neutral, 63–210 µm grade). Preparative 
TLC was performed on 0.75 mm silica gel glass plates. Preparative HPLC was carried out by using 
UV detection at 254 nm. Yields refer to chromatographically and spectroscopically homogenous 
materials. Melting points were measured on a melting point apparatus and were uncorrected. 
Specific rotations ([α]D) were measured at 589 nm. Only the strongest and/or structurally important 
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absorptions of infrared (IR) spectra are reported in reciprocal centimeters (cm-1). 1H NMR spectra 
(400 MHz) and 13C{1H}NMR spectra (100 MHz) were recorded in the indicated solvent. Chemical 
shifts are reported in delta (δ) units, parts per million (ppm). Chemical shifts for 1H NMR spectra are 
given relative to signals for internal tetramethylsilane (0 ppm) or residual nondeuterated solvents, 
i.e., chloroform (7.26 ppm) and methanol (3.30 ppm). Chemical shifts for 13C NMR spectra are 
given relative to the signal for chloroform-d (77.0 ppm) and methanol-d4 (49.0 ppm). Multiplicities 
are reported by the following abbreviations: s (singlet), d (doublet), t (triplet), q (quartet), m 
(multiplet), br (broad). Coupling constants (J) are represented in hertz (Hz). 1H and 13C NMR 
chemical shifts were assigned using a combination of COSY, NOESY, HMQC, and HMBC. Low 
and high-resolution mass spectra were measured on TOF-MS with EI, FAB, or ESI probe. 
 
(S)-1-((R)-2,2-Dimethyl-1,3-dioxolan-4-yl)but-3-yn-1-ol (13)17–19: Lithium chloride (8.48 g, 200 
mmol) was placed in a 300 mL, three-necked, round-bottomed flask, equipped with a magnetic 
stirring bar, a septum rubber, and a reflux condenser with a three-way stopcock connected to a 
balloon filled with argon. The flask was heated at 140 °C under reduced pressure (1 mmHg) for 4 h, 
during which time Zn powder (30 g, 0.46 g-atom) was activated by stirring with 1 M aqueous HCl 
(200 mL) for 15 min twice, before being washed with H2O (4 x 100 mL), EtOH (2 x 100 mL), and 
Et2O (100 mL) and dried at 80 °C for 2 h under reduced pressure (1 mmHg). Then the flask was 
cooled to room temperature before successive addition of activated Zn powder (19.6 g, 300 mg-
atom), anhydrous THF (100 mL), and 1,2-dibromoethane (0.86 mL, 10 mmol). To the stirred 
suspension was slowly added propargyl bromide (7.5 mL, 100 mmol) at room temperature while 
keeping the exothermic reaction gentle reflux. The resulting mixture was stirred at room temperature 
for 1.5 h and cooled to –78 °C before addition of a solution of freshly prepared and distilled 1216 
(10.8 g, 83.0 mmol) in anhydrous THF (40 mL). The reaction mixture was allowed to warm to room 
temperature over 8 h and treated with saturated aqueous NH4Cl (80 mL). The immiscible mixture 
was filtered through a Celite pad, which was thoroughly rinsed with EtOAc. The filtrate was 
separated and the organic layer was washed with brine, dried over MgSO4, and concentrated. The 
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residue was purified by silica gel column chromatography (20% EtOAc/hexane) to give 13 (10.3 g, 
73%) as a white solid. The spectroscopic data of 13 were in good agreement with those reported in 
the literature.17–19 
tert-Butyl(((S)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)but-3-yn-1-yl)oxy)dimethylsilane (11)14: 
To a stirred solution of alcohol 13 (17.0 g, 100 mmol) and imidazole (13.6 g, 200 mmol) in 
anhydrous CH2Cl2 (100 mL) was added tert-butyldimethylchlorosilane (19.6 g, 130 mmol) at room 
temperature. After being stirred at the same temperature for 26 h, the reaction mixture was treated 
with saturated aqueous NH4Cl (100 mL). The immiscible mixture was extracted with Et2O, washed 
with brine, dried over MgSO4, and concentrated. The residue was purified by silica gel column 
chromatography (3% EtOAc/hexane) to give 11 (27.0 g, 95%) as a pale yellow oil. The 
spectroscopic data of 11 were in good agreement with those reported in the literature.14 
3-Isopropoxycyclobut-3-ene-1,2-dione (9)13: To a stirred suspension of lithium aluminum 
hydride (3.98 g, 105 mmol) in anhydrous DME (52 mL) was added a solution of t-BuOH (31 mL, 
0.32 mol) in anhydrous DME (52 mL) at 0 °C. The resulting mixture was stirred at 0 °C for 30 min 
before addition of 1413 (14.9 g, 75.2 mmol). The reaction mixture was allowed to warm to room 
temperature over 1 h, cooled to 0 °C again, diluted with CH2Cl2 (675 mL), and treated with conc. 
HCl (44 mL). After being allowed to warm to room temperature over 4.5 h, the resulting mixture 
was treated with another conc. HCl (6 mL). The mixture was stirred at room temperature for 1 h, 
diluted with H2O (250 mL), extracted with CH2Cl2, washed with saturated aqueous NaHCO3, dried 
over MgSO4, and concentrated. The residue was purified by silica gel column chromatography (25–
30% EtOAc/hexane) to give 9 (7.54 g, 72%) as a pale yellow oil. The spectroscopic data of 9 were 
in good agreement with those reported in the literature.13 
(S)- and (R)-2-(2-((S)-2-((tert-Butyldimethylsilyl)oxy)-2-((R)-2,2-dimethyl-1,3-dioxolan-4-
yl)ethyl)–naphtho[1,8-de][1,3]dioxin-2-yl)-4-isopropoxycyclopent-4-ene-1,3-diones (16a·b): To 
a stirred solution of alkyne 11 (7.11 g, 25.0 mmol) in anhydrous THF (50 mL) was slowly added 
2.65 M BuLi solution (9.9 mL, 26 mmol) in hexane at –78 °C. The resulting mixture was stirred at 
the same temperature for 30 min before slow addition of a solution of diketone 9 (3.51 g, 25.0 
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mmol) in anhydrous THF (25 mL) at –78 °C. After being stirred at the same temperature for further 
1 h, the reaction mixture was treated with saturated aqueous NH4Cl (50 mL) and H2O (10 mL) at –
78 °C. The immiscible mixture was allowed to warm to room temperature, stirred for another 15 min, 
extracted with Et2O, washed with brine, dried over MgSO4, and concentrated to give a crude alcohol 
(11.7 g), which was used for the next reaction without further purification. 
To a stirred solution of the crude alcohol (11.7 g) in anhydrous Et2O (100 mL) were successively 
added NBS (5.34 g, 30.0 mmol, recrystallized from H2O) and Pd(TFA)2 (416 mg, 1.25 mmol) at 
room temperature. After being stirred at the same temperature for 75 min, the reaction mixture was 
treated with saturated aqueous NaHCO3 (25 mL) and 20% aqueous Na2S2O3·5H2O (25 mL). The 
immiscible mixture was extracted with Et2O, washed with H2O and brine successively, dried over 
MgSO4, and concentrated to give a crude bromide (12.2 g, 97%), which was used for the next 
reaction without further purification. 
To a stirred solution of the crude bromide (12.2 g) and 1,8-dihydroxynaphthalene (6) (1.94 g, 12.1 
mmol) in anhydrous CH3CN (48 mL) was added DABCO (2.04 g, 18.2 mmol) at room temperature. 
After being stirred at the same temperature for 10 h, the reaction mixture was concentrated. The 
residue was diluted with Et2O (50 mL) and filtered through a Celite pad, which was thoroughly 
rinsed with Et2O. The filtrate was washed with aqueous NH4Cl and brine successively, dried over 
MgSO4, and concentrated. The residue was purified by silica gel column chromatography (13% 
EtOAc/hexane) to give 16a·b (as a 1:1 diastereomeric mixture, 4.06 g, 58% based on 6) as a brown 
amorphous mass. Analytical sample of 16a·b (pure 58.2 mg along with impure 1l.6 mg) was 
obtained by further purification of the above material (100 mg) with preparative thin layer 
chromatography (17% EtOAc/toluene). 
Rf 0.44 (33% EtOAc/hexane). [α]D23.9 –1.08 (c 1.00, CHCl3). IR (compression cell, cm-1): 2933, 
1699, 1601, 1379, 1272, 1216, 1103, 1071, 836 cm-1. 1H-NMR (400 MHz, CDCl3): δ 7.47–7.38 (m, 
4H), 7.02–6.93 (m, 2H), 6.24 (s, 0.5H), 6.23 (0.5H), 4.47–4.36 (m, 2H), 4.30–4.24 (m, 1H), 3.97–
3.89 (m, 1H), 3.86–3.80 (m, 1H), 3.56 (s, 0.5H), 3.55 (s, 0.5H), 2.26–2.15 (m, 2H), 1.41–1.36 (m, 
9H), 1.30 (s, 3H), 0.86 (s, 4.5H), 0.85 (s, 4.5H), 0.08 (s, 1.5H), 0.06 (s, 1.5H), 0.03 (s, 1.5H), 0.02 (s, 
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1.5H). 13C-NMR (100 MHz, CDCl3): δ 193.6, 193.4, 192.7, 192.6, 170.99, 170.98, 146.50, 146.49, 
146.45, 134.0, 127.59, 127.54, 127.53, 127.47, 120.75, 120.72, 120.70, 120.66, 119.84, 119.78, 
113.19, 113.16, 109.9, 109.78, 109.75, 109.71, 108.93, 108.89, 100.9, 100.8, 78.7, 78.6, 76.51, 
76.48, 67.1, 67.0, 64.60, 64.57, 54.0, 53.9, 40.3, 40.2, 26.4, 26.3, 25.92, 25.90, 25.35, 25.32, 21.15, 
21.13, 21.04, 21.02, 18.08, 18.06, -4.48, -4.51, -4.52, -4.60. LRMS (EI) m/z (relative intensity): 582 
[M]+ (0.9), 567 (5), 525 (23), 467 (33), 323 (100), 313 (54), 281 (64), 211 (33), 149 (32). HRMS (EI, 
[M]+): calcd for C32H42O8Si, 582.2649; found 582.2640. 
(1S,3'S,4'S)- and (1R,3'S,4'S)-4'-((tert-Butyldimethylsilyl)oxy)-3-isopropoxy-3'-
(methoxymethoxy)dispiro–[cyclopentane-1,2'-cyclopentane-1',2''-naphtho[1,8-de][1,3]dioxin]-
3-ene-2,5-diones (18a and 18b): To a stirred solution of 11 (3.91 g, 6.71 mmol) in anhydrous 
EtOAc (34 mL) was added orthoperiodic acid (2.29 g, 10.0 mmol) at room temperature. After being 
stirred at the same temperature for 1.5 h, the reaction mixture was diluted with Et2O (34 mL) and 
filtered through a Celite pad, which was thoroughly rinsed with Et2O. The filtrate was concentrated 
to give a crude aldehyde 17a·b (3.71 g), which was used for the next reaction without further 
purification. 
To a stirred solution of the crude aldehyde 17a·b (3.70 g) and a catalytic amount of 
tetrabutylammonium iodide in anhydrous CH2Cl2 (13 mL) were successively added N,N-
diisopropylethylamine (11.5 mL, 68 mmol) and chloromethyl methyl ether (2.6 mL, 34 mmol) at 
room temperature. After being refluxed for 12 h, the reaction mixture was cooled to room 
temperature. The reaction mixture was treated with H2O. The immiscible mixture was extracted with 
Et2O twice. The combined organic layer was washed with brine, dried over MgSO4, and 
concentrated. The residue was purified by silica gel column chromatography (5–6% Et2O/toluene) to 
give 18a (1.00 g, 27% from 11 over 2 steps) and 18b (1.05 g, 28% from 11 over 2 steps) as a faster- 
and slower-moving component, respectively. 
18a as a yellow amorphous mass: Rf 0.47 (13% EtOAc/toluene). [α]D24.7 –151 (c 1.01, CHCl3). IR 
ν (compression cell, cm-1): 2930, 1701, 1604, 1244, 1085, 837. 1H NMR (400 MHz, CDCl3): δ 7.44–
7.40 (m, 3H), 7.34 (dd, J = 7.5, 8.3 Hz, 1H), 7.00 (dd, 1H, J = 2.7, 5.8 Hz), 6.79 (dd, J = 0.8, 7.5 Hz 
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1H), 6.13 (s, 1H), 4.89–4.84 (m, 1H), 4.68 (d, J = 7.0 Hz, 1H), 4.66 (d, J = 6.5 Hz, 1H), 4.54 (d, J = 
6.5 Hz, 1H), 4.26 (qq, J = 6.1, 6.1 Hz, 1H), 3.11 (s, 3H), 2.72 (dd, J = 9.5, 14.3 Hz, 1H), 2.11 (dd, J 
= 5.7, 14.3 Hz, 1H), 1.30 (d, J = 6.1 Hz, 3H), 1.21 (d, J = 6.1 Hz, 3H), 0.86 (s, 9H), 0.06 (s, 3H), 
0.00 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 193.9, 192.7, 171.6, 147.1, 146.9, 134.1, 127.7, 127.0, 
120.9, 120.6, 118.8, 113.3, 110.6, 109.4, 105.8, 97.6, 87.2, 76.2, 73.5, 66.5, 55.5, 44.1, 25.7, 21.1, 
20.9, 17.8, -4.8, -4.9. LRMS (EI) m/z (relative intensity): 554 [M]+ (9), 497 (72), 423 (60), 361 (70), 
319 (100), 241 (72). HRMS (EI, [M]+): calcd for C30H38O8Si, 554.2336; found 554.2295. 
18b as an orange amorphous mass: Rf 0.39 (13% EtOAc/toluene). [α]D25.0 –71.8 (c 1.01, CHCl3). 
IR ν (compression cell, cm-1): 2955, 2932, 1702, 1600, 1260, 1103, 1044, 837. 1H NMR (400 MHz, 
CDCl3): δ 7.44–7.38 (m, 3H), 7.33 (dd, J = 7.5, 8.3 Hz, 1H), 6.98 (dd, J = 1.7, 6.7 Hz, 1H), 6.78 (d, 
J = 7.5 Hz, 1H), 6.01 (s, 1H), 4.85–4.79 (m, 1H), 4.71 (d, J = 7.2 Hz, 1H), 4.67 (d, J = 6.5 Hz, 1H), 
4.52 (d, J = 6.5 Hz, 1H), 4.26 (qq, J = 6.1, 6.1 Hz, 1H), 3.13 (s, 3H), 2.64 (dd, J = 9.0, 14.2 Hz 1H), 
2.12 (dd, J = 6.6, 14.2 Hz, 1H), 1.34 (d, J = 6.1 Hz, 3H), 1.27 (d, J = 6.4 Hz, 3H), 0.85 (s, 9H), 0.06 
(s, 3H), 0.00 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 193.8, 192.6, 170.3, 146.92, 146.91, 133.9, 
127.6, 127.1, 121.0, 120.6, 119.8, 113.5, 110.6, 109.5, 105.8, 97.4, 85.7, 76.2, 73.2, 66.4, 55.8, 43.7, 
25.7, 21.1, 21.0, 17.8, -4.7, -4.9. LRMS (EI) m/z (relative intensity): 554 [M]+ (5), 467 (84), 361 (40), 
221 (51), 178 (45), 149 (100). HRMS (EI, [M]+): calcd for C30H38O8Si, 554.2336; found 554.2332. 
(1S,3'S,4'S)-4'-Hydroxy-3-isopropoxy-3'-(methoxymethoxy)dispiro[cyclopentane-1,2'-cyclo–
pentane-1',2''-naphtho[1,8-de][1,3]dioxin]-3-ene-2,5-dione (19a): To a stirred solution of 18a 
(891 mg, 1.61 mmol) in anhydrous THF (3.2 mL) was added 1.0 M tetrabutylammonium fluoride 
solution in THF (2.4 mL, 2.4 mmol) at 0 °C. The reaction mixture was allowed to warm to room 
temperature over 1.5 h and stirred for another 10.5 h at room temperature. The resulting mixture was 
treated with saturated aqueous NH4Cl (6 mL), extracted with ethyl acetate, washed with brine, dried 
over MgSO4, and concentrated. The residue was purified by silica gel column chromatography (50–
60% ethyl acetate/hexane) to give 19a (672mg, 95%) as a pale yellow solid. Rf 0.22 (25% 
EtOAc/toluene). Mp. 215–220 °C. [α]D22.0 –172 (c 1.01, CHCl3). IR ν (neat, cm-1): 3464, 2982, 2935, 
1698, 1599, 1272, 1237, 1101, 1044, 757. 1H NMR (400 MHz, CDCl3): δ 7.44–7.31 (m, 3H), 7.33 
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(dd, J = 7.5, 8.3 Hz, 1H), 6.99 (dd, J = 3.1, 5.3 Hz, 1H), 6.79 (dd, J = 0.8, 7.8 Hz, 1H), 6.09 (s, 1H), 
4.87–4.81 (m, 1H), 4.67 (d, J = 7.0 Hz, 1H), 4.59 (d, J = 7.0 Hz, 1H), 4.53 (d, J = 7.1 Hz, 1H), 4.19 
(qq, J = 6.1, 6.1 Hz, 1H), 3.55 (br-s, 1H), 3.38 (s, 3H), 2.89 (dd, J = 10.1, 14.7 Hz, 1H), 2.30 (dd, J = 
6.0, 14.7 Hz, 1H), 1.27 (d, J = 6.1 Hz, 3H), 1.14 (d, J = 6.0 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 
193.1, 192.5, 171.4, 147.0, 146.8, 134.1, 127.8, 127.0, 121.0, 120.7, 119.2, 113.1, 110.5, 109.4, 
105.3, 97.7, 89.0, 76.3, 71.9, 67.3, 56.0, 43.3, 21.0. HRMS (ESI, [M+Na]+): calcd for C24H24O8Na, 
463.1369; found: 463.1362. 
(1R,3'S,4'S)-4'-Hydroxy-3-isopropoxy-3'-(methoxymethoxy)dispiro[cyclopentane-1,2'-
cyclopentane-1',2''-naphtho[1,8-de][1,3]dioxin]-3-ene-2,5-dione (19b): Following the procedure 
described above for 19a, the desilylation of 18b (982 mg, 1.77 mmol) and flash column 
chromatography (50–60% ethyl acetate/hexane) afforded 19b (589 mg, 76%) as a pale brown 
amorphous mass. Rf 0.17 (25% EtOAc/toluene). [α]D25.1 –87.3 (c 1.01, CHCl3). IR ν (neat, cm-1): 
3449, 2929, 1699, 1599, 1412, 1379, 1272, 1237, 1103, 1045, 758. 1H NMR (400 MHz, CDCl3): δ 
7.44–7.39 (m, 3H), 7.32 (dd, J = 7.5, 8.2 Hz, 1H), 6.99 (dd, J = 2.1, 6.3 Hz, 1H), 6.78 (d, J = 7.5 Hz, 
1H), 5.94 (s, 1H), 4.84–4.78 (m, 1H), 4.67 (d, J = 7.0 Hz, 1H), 4.58 (d, J = 7.0 Hz, 1H), 4.53 (d, J = 
7.3 Hz, 1H), 4.22 (qq, J = 6.1, 6.1 Hz, 1H), 3.63 (br-s, 1H), 3.39 (s, 3H), 2.83 (dd, J = 9.7, 14.6 Hz, 
1H), 2.29 (dd, J = 6.8, 14.6 Hz, 1H), 1.35 (d, J = 6.1 Hz, 3H), 1.25 (d, J = 6.1 Hz, 3H). 13C NMR 
(100 MHz, CDCl3): δ 193.3, 192.3, 170.3, 146.9, 146.8, 133.9, 127.7, 127.0, 121.1, 120.7, 119.9, 
113.4, 110.5, 109.4, 105.5, 97.5, 88.2, 76.4, 71.6, 67.1, 56.0, 43.0, 21.1, 20.9. HRMS (ESI, 
[M+Na]+): calcd for C24H24O8Na, 463.1369; found: 463.1362. 
(1S,5'R)-3-Isopropoxy-5'-(methoxymethoxy)dispiro[cyclopentane-1,1'-cyclopentane-2',2''-
naphtho[1,8-de][1,3]dioxine]-3,3'-diene-2,5-dione (20a): To a stirred solution of alcohol 19a (494 
mg, 1.12 mmol) in anhydrous CH2Cl2 (5.6 mL) were successively added triethylamine (0.47 mL, 3.4 
mmol) and methanesulfonyl chloride (0.13 mL, 1.7 mmol) at 0 °C. The reaction mixture was 
allowed to warm to room temperature over 2 h and treated with N,N-dimethyl-1,3-propanediamine 
(143 µL, 1.15 mmol). The resulting mixture was stirred for another 30 min, diluted with EtOAc, 
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washed with 1 M aqueous HCl, H2O, saturated aqueous NaHCO3, and brine successively, dried over 
MgSO4, and concentrated to give a crude mesylate (604 mg) as a pale yellow amorphous mass. 
Mesylate of 19a: Rf 0.33 (25% EtOAc/toluene). 1H NMR (400 MHz, CDCl3): δ 7.48–7.42 (m, 
3H), 7.34 (dd, J = 7.5, 8.3 Hz, 1H), 7.03 (dd, J = 1.5, 6.9 Hz, 1H), 6.79 (dd, J = 0.8, 7.5 Hz, 1H), 
6.27 (s, 1H), 5.61–5.56 (m, 1H), 4.96 (d, J = 6.4 Hz, 1H), 4.62 (d, J = 6.8 Hz, 1H), 4.58 (d, J = 6.8 
Hz, 1H), 4.35 (qq, J = 6.1, 6.1 Hz, 1H), 3.19 (s, 3H), 3.04 (s, 3H), 3.02 (dd, J = 10.1, 15.2 Hz, 1H), 
2.46 (dd, J = 3.9, 15.2 Hz, 1H), 1.33 (d, J = 6.1 Hz, 3H), 1.26 (d, J = 6.1 Hz, 3H). 13C NMR (100 
MHz, CDCl3): δ 192.8, 191.2, 172.1, 146.6, 146.2, 134.1, 127.8, 127.1, 121.3, 121.0, 119.0, 113.0, 
110.5, 109.4, 105.2, 97.5, 83.6, 80.9, 76.6, 66.1, 55.9, 41.7, 38.0, 21.1, 20.9. LRMS (EI) m/z 
(relative intensity): 518 [M]+ (100), 422 (72), 335 (52). HRMS (EI, [M]+): calcd for C25H26O10S, 
518.1247; found 518.1205. 
To a stirred solution of the crude mesylate (604 mg) in anhydrous toluene (5.6 mL) was added 
DBU (0.50 mL, 3.4 mmol) at room temperature. After being refluxed for 28 h, the reaction mixture 
was cooled to room temperature and concentrated. The residue was purified by silica gel 
chromatography (40% EtOAc/hexane) to give pure 20a (268 mg, 57% from 19a over 2 steps) as a 
colorless solid and impure 20a (34 mg). The latter was further purified by preparative thin layer 
chromatography (50% EtOAc/hexane, developed 3 times) to give another pure 20a (18 mg, 4% from 
19a over 2 step).  
20a: Rf 0.33 (50% EtOAc/hexane). Mp. 151–154 °C. [α]D27.5 –288 (c 1.18, CHCl3). IR ν (neat, cm-
1): 2987, 2935, 1700, 1600, 1413, 1379, 1275, 1233, 1103, 1040, 757. 1H NMR (400 MHz, CDCl3): 
δ 7.44–7.38 (m, 3H), 7.35 (dd, J = 7.5, 8.3 Hz, 1H), 6.89 (dd, J = 1.8, 6.6 Hz, 1H), 6.86 (d, J = 7.5 
Hz, 1H), 6.50 (dd, J = 1.6, 5.9 Hz, 1H), 6.09 (s, 1H), 6.00 (dd, J = 2.1, 5.9 Hz, 1H), 5.30 (dd, J = 1.6, 
2.1 Hz, 1H), 4.60 (d, J = 6.8 Hz, 1H), 4.58 (d, J = 6.8 Hz, 1H), 4.14 (qq, J = 6.1, 6.2 Hz, 1H), 3.21 (s, 
3H), 1.26 (d, J = 6.2 Hz, 3H), 1.12 (d, J = 6.1 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 193.2, 191.4, 
170.7, 147.6, 147.4, 139.4, 134.2, 129.0, 127.8, 127.2, 120.8, 120.5, 119.5, 113.0, 109.9, 109.25, 
109.23, 97.7, 83.9, 76.2, 68.3, 55.7, 21.0, 20.9. HRMS (ESI, [M+Na]+): calcd for C24H22O7Na, 
445.1263; found: 445.1256. 
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(1R,5'R)-3-Isopropoxy-5'-(methoxymethoxy)dispiro[cyclopentane-1,1'-cyclopentane-2',2''-
naphtho[1,8-de][1,3]dioxine]-3,3'-diene-2,5-dione (20b): Following the procedure described above 
for 20a, the dehydration of 19b (505 mg, 1.15 mmol) and flash column chromatography (33% 
EtOAc/hexane) afforded 20b (290 mg, 60%) as a pale yellow amorphous mass.  
Mesylate of 19b: Rf 0.29 (25% EtOAc/toluene). 1H NMR (400 MHz, CDCl3): δ 7.47–7.41 (m, 
3H), 7.33 (dd, J = 7.5, 8.2 Hz, 1H), 7.02 (d, J = 7.1 Hz, 1H), 6.78 (d, J = 7.5 Hz, 1H), 6.14 (s, 1H), 
5.57–5.52 (m, 1H), 5.01 (d, J = 6.4 Hz, 1H), 4.63 (d, J = 6.8 Hz, 1H), 4.58 (d, J = 6.8 Hz, 1H), 4.37 
(qq, J = 6.1, 6.1 Hz, 1H), 3.22 (s, 1H), 3.04 (s, 3H), 2.97 (dd, J = 9.8, 15.2 Hz, 1H), 2.46 (dd, J = 4.3, 
15.2 Hz, 1H), 1.40 (d, J = 6.1 Hz, 3H), 1.36 (d, J = 6.1 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 
192.0, 191.9, 170.5, 146.5, 146.2, 134.0, 127.7, 127.0, 121.4, 121.1, 120.6, 113.1, 110.5, 109.3, 
105.3, 97.3, 82.4, 80.5, 76.6, 66.0, 56.1, 41.4, 38.1, 21.1, 21.0. LRMS (EI) m/z (relative intensity): 
518 [M]+ (100), 422 (52), 335 (49). HRMS (EI, [M]+): calcd for C25H26O10S, 518.1247; found 
518.1198. 
20b: Rf 0.43 (50% EtOAc/hexane). [α]D28.6 —243 (c 0.985, CHCl3). IR ν (neat, cm-1): 2982, 2929, 
1704, 1601, 1413, 1379, 1276, 1234, 1104, 1046, 756. 1H NMR (400 MHz, CDCl3): δ 7.45–7.37 (m, 
3H), 7.33 (dd, J = 7.5, 8.4 Hz, 1H), 6.90 (dd, J = 1.3, 7.8 Hz, 1H), 6.84 (d, J = 7.5 Hz, 1H), 6.48 (dd, 
J = 1.7, 5.9 Hz, 1H), 5.99 (dd, J = 2.0, 5.9 Hz, 1H), 5.94 (s, 1H), 5.34 (dd, J = 1.7, 2.0 Hz, 1H), 4.60 
(d, J = 6.9 Hz, 1H), 4.57 (d, J = 6.9 Hz, 1H), 4.22 (qq, J = 6.1, 6.2 Hz, 1H), 3.22 (s, 3H), 1.35 (d, J = 
6.1 Hz, 3H), 1.25 (d, J = 6.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 194.1, 190.2, 170.9, 147.5, 
147.2, 139.4, 134.0, 129.1, 127.6, 127.1, 121.0, 120.5, 119.1, 113.4, 109.88, 109.86, 109.2, 97.6, 
83.1, 76.3, 67.9, 55.9, 21.1, 21.0. HRMS (ESI, [M+Na]+): calcd for C24H22O7Na, 445.1263; found: 
445.1256. 
(1S,5'R)-5'-Hydroxy-3-isopropoxydispiro[cyclopentane-1,1'-cyclopentane-2',2''-naphtho[1,8-
de][1,3]dioxine]-3,3'-diene-2,5-dione (21a): To a solution of 20a (10.0 mg, 0.0237 mmol) in DME 
(0.2 mL) was added 3 M aqueous HCl (0.1 mL) at room temperature. The resulting mixture was 
stirred at 65 °C for 2 h, cooled to room temperature, and diluted with EtOAc. The immiscible 
mixture was washed with saturated aqueous NaHCO3 and brine successively, dried over MgSO4, 
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and concentrated to give crude 21a (10.4 mg) as a pale yellow amorphous. Rf 0.18 (25% 
EtOAc/toluene). [α]D23.3 –145 (c 0.520, CHCl3). IR ν (compression cell, cm-1): 3477, 2982, 2926, 
1695, 1597, 1274, 1232, 1079, 757. 1H NMR (400 MHz, CDCl3): δ 7.46–7.41 (m, 3H), 7.38 (dd, J = 
7.5, 8.3 Hz, 1H), 6.89–6.87 (m, 2H), 6.44 (dd, J = 1.8, 5.8 Hz, 1H), 6.05 (dd, J = 1.7, 5.8 Hz, 1H), 
6.00 (s, 1H), 5.37 (d, J = 12.3 Hz, 1H), 4.09 (qq, J = 6.1, 6.2 Hz, 1H), 2.79 (d, J = 12.3 Hz, 1H), 
1.26 (d, J = 6.1 Hz, 3H), 1.12 (d, J = 6.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 194.8, 192.9, 
171.4, 147.3, 147.1, 141.4, 134.1, 130.0, 127.9, 127.3, 120.9, 120.7, 119.3, 113.1, 110.3, 109.9, 
109.5, 78.3, 76.8, 68.0, 20.92, 20.90. LRMS (EI) m/z (relative intensity): 378 [M]+ (85), 267 (100). 
HRMS (EI, [M]+): calcd for C22H18O6, 378.1103; found 378.1095. 
(1R,5'R)-5'-Hydroxy-3-isopropoxydispiro[cyclopentane-1,1'-cyclopentane-2',2''-naphtho[1,8-
de][1,3]dioxine]-3,3'-diene-2,5-dione (21b): Following the procedure described above for 21a, the 
acid hydrolysis of 20b (10.2 mg, 0.0241 mmol) gave crude 21b (10.0 mg) as a pale yellow 
amorphous mass. Rf 0.18 (25% EtOAc/toluene). [α]D22.0 –93.7 (c 0.500, CHCl3). IR ν (compression 
cell, cm-1): 3446, 2983, 2930, 1695, 1598, 1273, 1232, 1094, 757. 1H NMR (400 MHz, CDCl3): δ 
7.46–7.34 (m, 4H), 6.90 (d, J = 7.3 Hz, 1H), 6.86 (d, J = 7.5 Hz, 1H), 6.43 (dd, J = 1.9, 5.8 Hz, 1H), 
6.04 (dd, J = 1.6, 5.8 Hz, 1H), 5.96 (s, 1H), 5.40 (d, J = 12.0 Hz, 1H), 4.17 (qq, J = 6.1, 6.2 Hz, 1H), 
2.55 (d, J = 12.0 Hz, 1H), 1.32 (d, J = 6.2 Hz, 3H), 1.20 (d, J = 6.1 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): δ 193.61, 193.56, 170.7, 147.3, 146.9, 140.8, 133.9, 130.2, 127.6, 127.3, 121.1, 120.7, 
120.0, 113.4, 110.3, 110.1, 109.6, 77.6, 67.5, 21.03, 20.98. LRMS (EI) m/z (relative intensity): 378 
[M]+ (85), 267 (100). HRMS (EI, [M]+): calcd for C22H18O6, 378.1103; found 378.1089. 
Purification of the crude 21b with preparative thin layer chromatography (33% EtOAc/toluene) 
resulted in the formation of a 1:1 mixture of 21a and 21b. 
(1S*,5'R*)- and (1R*,5'R*)-3-Isopropoxy-5'-(methoxymethoxy)dispiro[cyclopentane-1,1'-
cyclopentane-2',2''-naphtho[1,8-de][1,3]dioxine]-3,3'-diene-2,5-dione ((±)-20a and (±)-20b): To 
a stirred solution of the crude aldol 21b (18.7 mg, obtained from 20b (21.0 mg, 0.0497 mmol)) and a 
catalytic amount of tetrabutylammonium iodide in anhydrous CH2Cl2 (0.4 mL) were successively 
added N,N-diisopropylethylamine (87 µL, 0.50 mmol) and chloromethyl methyl ether (19 µL, 0.25 
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mmol) at room temperature. After being refluxed for 15 h, the reaction mixture was cooled to room 
temperature, diluted with Et2O, washed with saturated aqueous NH4Cl and brine successively, dried 
over MgSO4, and concentrated. The residue was purified by preparative thin layer chromatography 
(20% EtOAc/toluene, developed 6 times) to give (±)-20a (7.7 mg, 37% from 20b over 2 steps) and 
(±)-20b (8.8 mg, 42% from 20b over 2 steps) as a slower- and faster-moving component, 
respectively. 
(±)-20a: Rf 0.26 (25% EtOAc/toluene). [α]D25.5 –1.8 (c 0.39, CHCl3). 
(±)-20b: Rf 0.33 (25% EtOAc/toluene). [α]D23.7 —1.8 (c 0.44, CHCl3). 
(1S,2R,5'R)- and (1S,2S,5'R)-2-Hydroxy-3-isopropoxy-5'-(methoxymethoxy)dispiro[cyclo–
pentane-1,1'-cyclopentane-2',2''-naphtho[1,8-de][1,3]dioxine]-3,3'-dien-5-ones (22a and 22a'): 
To a stirred suspension of enone 20a (170 mg, 0.401 mmol) in EtOH (4 mL) was portionwise added 
potassium borohydride (65.7 mg, 1.22 mmol) at 0 °C. The reaction mixture was allowed to warm to 
room temperature over 4 h and treated with saturated aqueous NH4Cl (4 mL). The resulting mixture 
was stirred for another 1 h, extracted with EtOAc, washed with brine, dried over MgSO4, and 
concentrated. The residue was purified by preparative thin layer chromatography (50% 
EtOAc/toluene, developed 2 times) to give pure 22a (144 mg, 84%) and impure 22a' (20.4 mg) as a 
slower- and faster-moving component, respectively. The latter was further purified by preparative 
thin layer chromatography (30% acetone/hexane, developed 2 times) to give pure 22a' (12.0 mg, 
7%).  
22a as a white amorphous mass: Rf 0.25 (40% EtOAc/toluene). [α]D23.4 –299 (c 1.39, CHCl3). IR ν 
(neat, cm-1): 3397, 2982, 2929, 1072, 1602, 1411, 1379, 1274, 1130, 1104, 1053, 1041, 755. 1H 
NMR (400 MHz, CDCl3): δ. 7.47–7.44 (m, 2H), 7.40–7.35 (m, 2H), 6.91 (d, J = 7.5 Hz, 1H), 6.85 (d, 
J = 7.5 Hz 1H), 6.32 (dd, J = 1.6, 6.1 Hz, 1H), 5.95 (dd, J = 2.2, 6.1 Hz, 1H), 5.46 (s, 1H), 5.36–5.33 
(m, 2H), 4.84 (d, J = 7.1 Hz, 1H), 4.76 (d, J = 7.1 Hz, 1H), 4.50 (qq, J = 6.1, 6.2 Hz, 1H), 3.85 (d, J 
= 9.1 Hz, 1H), 3.38 (s, 3H), 1.42 (d, J = 6.1 Hz, 3H), 1.40 (d, J = 6.2 Hz, 3H). 13C NMR (100 MHz, 
CDCl3): δ 196.0, 184.8, 147.88, 147.87, 139.1, 134.2, 127.8, 127.3, 127.2, 120.7, 120.5, 113.8, 
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109.8, 109.5, 108.9, 105.7, 97.9, 82.5, 75.8, 71.2, 70.3, 55.8, 21.5, 21.3. HRMS (ESI, [M+Na]+): 
calcd for C24H24O7Na, 447.1420; found: 447.1411. 
22a' as a white amorphous mass: Rf 0.35 (40% EtOAc/toluene). [α]D19.7 –318 (c 0.770, CHCl3). IR 
ν (compression cell, cm-1): 3533, 2933, 1709, 1605, 1273, 1107, 1042, 757. 1H NMR (400 MHz, 
CDCl3): δ. 7.52–7.48 (m, 2H), 7.43–7.36 (m, 2H), 7.01 (dd, J = 0.8, 7.6 Hz, 1H), 6.87 (d, J = 6.9 Hz 
1H), 6.36 (dd, J = 1.4, 6.2 Hz, 1H), 6.05 (dd, J = 2.0, 6.2 Hz, 1H), 5.52 (s, 1H), 5.16 (d, J = 1.8 Hz, 
1H), 5.14 (dd, J = 1.4, 2.0 Hz, 1H), 4.72 (d, J = 7.0 Hz, 1H), 4.65 (d, J = 7.0 Hz, 1H), 4.52 (qq, J = 
6.1, 6.2 Hz, 1H), 4.21 (d, J = 1.8 Hz, 1H), 3.35 (s, 3H), 1.45 (d, J = 6.2 Hz, 3H), 1.41 (d, J = 6.1 Hz, 
3H). 13C NMR (100 MHz, CDCl3): δ 196.1, 184.3, 147.4, 146.8, 138.8, 134.2, 129.6, 127.6, 126.9, 
121.5, 120.9, 113.9, 110.8, 110.7, 109.4, 106.5, 96.3, 84.2, 75.8, 75.7, 67.3, 55.6, 21.4, 21.2. LRMS 
(EI) m/z (relative intensity): 424 [M]+ (86), 362 (45), 265 (43), 223 (100). HRMS (EI, [M]+): calcd 
for C24H24O7, 424.1522; found 424.1509. 
(1R,2R,5'R)-2-Hydroxy-3-isopropoxy-5'-(methoxymethoxy)dispiro[cyclopentane-1,1'-cyclo–
pentane-2',2''-naphtho[1,8-de][1,3]dioxine]-3,3'-dien-5-one (22b): To a stirred suspension of 
enone 20b (168 mg, 0.398mmol) in EtOH (4 mL) was portionwise added sodium borohydride (45.0 
mg, 1.19 mmol) at 0 °C. The reaction mixture was allowed to warm to room temperature over 2 h 
and treated with saturated aqueous NH4Cl (5 mL). The resulting mixture was stirred for another 1 h, 
extracted with EtOAc, washed with brine, dried over MgSO4, and concentrated. The residue was 
purified by preparative thin layer chromatography (50% EtOAc/hexane) to give 22b (167 mg, 99%) 
as a white amorphous mass. Rf 0.34 (40% EtOAc/toluene). [α]D23.4 —97.8 (c 1.01, CHCl3). IR ν (neat, 
cm-1): 3559, 2982, 2935, 1699, 1606, 1586, 1413, 1379, 1273, 1105, 1033, 757. 1H NMR (400 MHz, 
CDCl3): δ 7.52–7.45 (m, 2H), 7.42–7.36 (m, 2H), 6.94 (dd, J = 1.0, 7.5 Hz 1H), 6.90 (dd, J = 0.8, 
7.5 Hz, 1H), 6.43 (dd, 1H, J = 1.9, 6.0 Hz), 5.94 (dd. 1H, J = 1.7, 6.0 Hz), 5.32 (dd, J = 0.8, 10.1 Hz, 
1H), 5.27 (dd, J = 1.7, 1.9 Hz, 1H), 5.18 (br-s, 1H), 4.77 (d, J = 6.6 Hz, 1H), 4.75 (d, J = 6.6 Hz, 1H), 
4.39 (qq, J = 6.1, 6.1 Hz, 1H), 3.82 (d, J = 10.1 Hz, 1H), 3.38 (s, 3H), 1.40 (d, J = 6.1 Hz, 3H), 1.38 
(d, J = 6.1 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 195.3, 185.3, 147.3, 146.8, 139.9, 134.1, 128.9, 
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127.8, 126.8, 121.5, 120.6, 113.5, 110.9, 110.2, 108.7, 102.6, 97.0, 80.1, 75.9, 71.6, 70.3, 55.6, 
21.32, 21.26. HRMS (ESI, [M+Na]+): calcd for C24H24O7Na, 447.1420; found: 447.1412. 
(1R,5R,5'R)-4-Isopropoxy-5'-(methoxymethoxy)-2-oxodispiro[cyclopentane-1,1'-cyclopent–
ane-2',2''-naphtho[1,8-de][1,3]dioxine]-3,3'-dien-5-yl acetate (23a): To a stirred solution of 
alcohol 22a (10.9 mg, 0.0257 mmol) and a catalytic amount of DMAP in anhydrous CH2Cl2 (0.5 
mL) were successively added triethylamine (17 µL, 0.12 mmol) and acetic anhydride (7 µL, 0.074 
mmol) at room temperature. After being stirred at the same temperature for 1 h, the reaction mixture 
was treated with N,N-dimethyl-1,3-propanediamine (10 µL, 0.080 mmol). The resulting mixture was 
stirred for another 30 min, diluted with EtOAc, washed with 1 M aqueous HCl, H2O, saturated 
aqueous NaHCO3, and brine successively, dried over MgSO4, and concentrated. The residue was 
purified by preparative thin layer chromatography (33% EtOAc/toluene) to give 23a (10.6 mg, 88%) 
as a white amorphous mass. Rf 0.38 (40% EtOAc/toluene). [α]D23.1 –262 (c 0.530, CHCl3). IR ν (neat, 
cm-1): 2935, 1756, 1717, 1607, 1379, 1368, 1273, 1227, 1104, 756. 1H NMR (400 MHz, CDCl3): δ. 
7.45–7.43 (m, 2H), 7.39–7.33 (m, 2H), 6.92 (d, J = 7.5 Hz, 1H), 6.76 (d, J = 7.8 Hz, 1H), 6.73 (s, 
1H), 6.32 (dd, J = 1.4, 6.2 Hz, 1H), 5.99 (dd, J = 2.0, 6.2 Hz, 1H), 5.48 (s, 1H), 5.23 (br-s, 1H), 4.82 
(d, J = 6.8 Hz, 1H), 4.70 (d, J = 6.8 Hz, 1H), 4.44 (septet, J = 6.1 Hz, 1H), 3.42 (s, 3H), 2.26 (s, 3H), 
1.35 (d, J = 6.1 Hz, 6H). 13C NMR (100 MHz, CDCl3): δ 195.2, 181.8, 168.8, 147.7, 147.6, 138.7, 
134.2, 128.2, 127.3, 127.2, 120.7, 120.5, 113.7, 109.8, 108.9, 108.7, 106.7, 96.1, 79.8, 76.0, 69.8, 
69.1, 55.5, 21.3, 21.2, 20.9. HRMS (ESI, [M+Na]+): calcd for C26H26O8Na, 489.1525; found: 
489.1516. 
(1R,5S,5'R)-4-Isopropoxy-5'-(methoxymethoxy)-2-oxodispiro[cyclopentane-1,1'-cyclopent–
ane-2',2''-naphtho[1,8-de][1,3]dioxine]-3,3'-dien-5-yl acetate (23a'): Following the procedure 
described above for 23a, the acetylation of 22a' (11.4 mg, 0.0269 mmol) and preparative thin layer 
chromatography (33% EtOAc/toluene) afforded 23a' (11.1 mg, 89%) as a white amorphous mass. Rf 
0.44 (40% EtOAc/toluene). [α]D18.1 –330 (c 0.555, CHCl3). IR ν (neat, cm-1): 2935, 1748, 1716, 1609, 
1379, 1274, 1236, 1105, 1043. 1H NMR (400 MHz, CDCl3): δ. 7.47–7.33 (m, 4H), 6.96 (d, J = 7.4 
Hz, 1H), 6.76 (d, J = 6.9 Hz, 1H), 6.42 (s, 1H), 6.32 (dd, J = 1.3, 6.2 Hz, 1H), 6.04 (dd, J = 2.0, 6.2 
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Hz, 1H), 5.59 (s, 1H), 5.23 (br-s, 1H), 4.75 (d, J = 7.0 Hz, 1H), 4.72 (d, J = 7.0 Hz, 1H), 4.49 (septet, 
J = 6.1 Hz, 1H), 3.37 (s, 3H), 1.78 (s, 3H), 1.38 (d, J = 6.1 Hz, 6H). 13C NMR (100 MHz, CDCl3): δ 
195.9, 181.7, 170.5, 147.6, 147.3, 137.9, 134.2, 130.1, 127.4, 127.2, 120.6, 120.3, 113.3, 109.9, 
109.0, 108.5, 107.9, 96.8, 85.0, 75.9, 73.1, 66.5, 55.6, 21.4, 21.2, 20.6. LRMS (EI) m/z (relative 
intensity): 466 [M]+ (100), 320 (68), 223 (66). HRMS (EI, [M]+): calcd for C26H26O8, 466.1628; 
found 466.1603. 
(1S,5R,5'R)-4-Isopropoxy-5'-(methoxymethoxy)-2-oxodispiro[cyclopentane-1,1'-cyclopent–
ane-2',2''-naphtho[1,8-de][1,3]dioxine]-3,3'-dien-5-yl acetate (23b): Following the procedure 
described above for 23a, the acetylation of 22b (10.8 mg, 0.0254 mmol) and preparative thin layer 
chromatography (33% EtOAc/toluene) afforded 23b (10.5 mg, 88%) as a white amorphous mass. Rf 
0.44 (40% EtOAc/toluene). [α]D22.8 +118 (c 0.525, CHCl3). IR ν (neat, cm-1): 2982, 2939, 1752, 
1711, 1608, 1413, 1380, 1276, 1238, 1103, 1037, 756. 1H NMR (400 MHz, CDCl3): δ 7.47–7.34 (m, 
4H), 6.95 (dd, J = 0.9, 7.8 Hz, 1H), 6.86 (d, J = 6.8 Hz, 1H), 6.65 (s, 1H), 6.31 (dd, J = 2.5, 6.1 Hz, 
1H), 6.12 (d. J = 6.1 Hz, 1H), 5.33 (s, 1H), 4.82 (d, J = 6.9 Hz, 1H), 4.75 (d, J = 6.9 Hz, 1H), 4.67 (d, 
J = 2.5 Hz, 1H), 4.42 (qq, J = 6.2, 6.2 Hz, 1H), 3.40 (s, 3H), 1.82 (s, 3H), 1.38 (d, J = 6.2 Hz, 3H), 
1.36 (d, J = 6.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 197.3, 182.3, 170.0, 147.9, 147.4, 136.7, 
134.1, 132.5, 127.4, 127.2, 120.4, 120.3, 113.5, 110.0, 109.7, 108.5, 104.2, 96.5, 82.5, 76.1, 70.6, 
66.4, 55.7, 21.3, 21.2, 20.8. HRMS (ESI, [M+Na]+): calcd for C26H26O8Na, 489.1525; found: 
489.1516. 
(1S,2S,5'R)-2-Hydroxy-5'-(methoxymethoxy)dispiro[cyclopentane-1,1'-cyclopentane-2',2''-
naphtho[1,8-de][1,3]dioxin]-3'-en-5-one (24) and (2S,5S,5'R)-5'-(methoxymethoxy)dispiro–
[cyclopentane-1,1'-cyclopentane-2',2''-naphtho[1,8-de][1,3]dioxin]-3'-ene-2,5-diol (25): To a 
stirred solution of alcohol 22a (8.3 mg, 0.020 mmol) in anhydrous THF (0.4 mL) was added 1.0 M 
lithium aluminum hydride solution in THF (0.06 mL, 0.06 mmol) at 0 °C. The reaction mixture was 
allowed to warm to room temperature over 2 h, cooled to 0 °C again, and treated with saturated 
aqueous Na2SO4·10H2O (13 µL). The resulting mixture was stirred at room temperature for 1 h, 
dried over MgSO4, diluted with EtOAc, and filtered through a Celite pad, which was thoroughly 
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rinsed with EtOAc. The filtrate was concentrated. The residue was purified by preparative thin layer 
chromatography (50% EtOAc/hexane) to give impure hydroxy-ketone 24 (4.3 mg) and diol 25 (1.6 
mg) as a faster- and slower-moving component, respectively. The former and latter were further 
purified by preparative thin layer chromatography (40% EtOAc/toluene and 20% acetone/toluene, 
respectively) to give pure 24 (3.9 mg, 54%) as a white solid and 25 (1.3 mg, 18%) as a white 
amorphous mass. 
24: Rf 0.44 (60% EtOAc/hexane), 0.21 (30% acetone/hexane), 0.43 (40% EtOAc/toluene) and 0.45 
(20% acetone/toluene). Mp. 182–186 °C. [α]D20.6 –310 (c 1.02, CHCl3). IR ν (neat, cm-1): 3591, 3491, 
3016, 2951, 1752, 1607, 1412, 1275, 1098, 1043, 757. 1H NMR (400 MHz, CDCl3): δ 7.50–7.47 (m, 
2H), 7.43–7.36 (m, 2H), 6.94 (dd, J = 0.8, 7.5 Hz, 1H), 6.81 (dd, J = 0.7, 7.5 Hz, 1H), 6.37 (dd, J = 
1.4, 6.1 Hz, 1H), 5.94 (dd, J = 1.9, 6.1 Hz, 1H), 5.40 (dd, J = 1.4, 1.9 Hz, 1H), 5.01–4.96 (m, 1H), 
4.87 (d, J = 6.9 Hz, 1H), 4.71 (d, J = 6.9 Hz, 1H), 3.41 (s, 3H), 2.87–2.85 (m, 1H), 2.60—2.52 (m, 
1H), 2.44—2.32 (m, 2H), 2.06—1.98 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 208.9, 147.6, 147.4, 
139.6, 134.2, 128.3, 127.5, 127.1, 121.0, 120.9, 113.7, 110.2, 110.0, 108.9, 96.8, 80.1, 71.6, 69.7, 
55.8, 38.0, 27.3. HRMS (ESI, [M+Na]+): calcd for C21H20O6Na, 391.1158; found: 391.1151. 
25: Rf 0.43 (60% EtOAc/hexane), 0.18 (30% acetone/hexane), 0.23 (40% EtOAc/toluene) and 0.26 
(20% acetone/toluene). [α]D17.8 +56 (c 0.37, CHCl3). IR ν (compression cell, cm-1): 3578, 3432, 2951, 
1607, 1275, 1095, 1033, 756. 1H NMR (400 MHz, CDCl3): δ 7.53–7.50 (m, 2H), 7.44–7.40 (m, 2H), 
6.99 (d, J = 7.5 Hz, 1H), 6.92 (d, J = 7.5 Hz, 1H), 6.35 (dd, J = 2.6, 6.0 Hz, 1H), 5.99 (d, J = 6.0 Hz, 
1H), 5.36–5.32 (m, 1H), 4.78–4.74 (m, 3H), 4.70 (d, J = 2.6 Hz, 1H), 3.39 (s, 3H), 2.85 (br-s, 1H), 
2.46–2.37 (m, 1H), 2.18–2.10 (m, 1H), 1.85–1.66 (m, 3H). 13C NMR (100 MHz, CDCl3): δ 148.1, 
147.5, 139.7, 134.3, 130.6, 127.4, 127.3, 121.1, 120.9, 114.0, 112.0, 109.8, 109.5, 97.0, 81.3, 74.2, 
73.5, 63.3, 55.6, 28.7, 28.2. LRMS (EI) m/z (relative intensity): 370 [M]+ (5), 352 (100), 291 (36), 
160 (72). HRMS (EI, [M]+): calcd for C21H22O6, 370.1416; found 370.1419. 
(R)-5'-(Methoxymethoxy)dispiro[cyclopentane-1,1'-cyclopentane-2',2''-naphtho[1,8-de][1,3]–
dioxin]-3'-ene-2,5-dione (26): To a stirred solution of hydroxy-ketone 24 (13.4 mg, 0.0364 mmol) 
in anhydrous CH2Cl2 (0.4 mL) was added Dess-Martin periodinane (31.3 mg, 0.0738 mmol) at room 
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temperature. After being stirred at the same temperature for 2.5 h, the reaction mixture was treated 
with saturated aqueous NaHCO3 (2 mL), 20% aqueous Na2S2O3·5H2O (2 mL), and Et2O (4 mL). 
The immiscible mixture was stirred for 2.5 h, extracted with Et2O, washed with brine, dried over 
MgSO4, and concentrated. The residue was purified by preparative thin layer chromatography (20% 
EtOAc/toluene) to give 26 (11.9 mg, 89%) as a white amorphous mass. Rf 0.61 (40% 
EtOAc/toluene). [α]D20.0 –195 (c 0.595, CHCl3). IR ν (neat, cm-1): 3019, 2929, 1736, 1608, 1412, 
1379, 1274, 1096, 1039, 758. 1H NMR (400 MHz, CDCl3): δ 7.52–7.47 (m, 2H), 7.43–7.38 (m, 2H), 
6.93 (d, J = 7.5 Hz, 1H), 6.89 (d, J = 7.5 Hz, 1H), 6.43 (dd, J = 1.7, 5.9 Hz, 1H), 5.82 (dd, J = 2.2, 
5.9 Hz, 1H), 5.26 (dd, J = 1.7, 2.2 Hz, 1H), 4.63 (d, J = 6.5 Hz, 1H), 4.60 (d, J = 6.5 Hz, 1H), 3.22 (s, 
3H), 2.92–2.80 (m, 1H), 2.67–2.44 (m, 3H). 13C NMR (100 MHz, CDCl3): δ 207.7, 204.1, 147.1, 
146.9, 139.5, 134.0, 127.6, 127.3, 126.7, 121.4, 120.9, 113.5, 110.7, 109.9, 109.7, 98.4, 83.7, 71.8, 
55.8, 37.2, 36.1. HRMS (ESI, [M+Na]+): calcd for C21H18O6Na, 389.1001; found: 389.0994. 
Following the procedure described above for 26, the oxidation of diol 25 (7.4 mg, 0.020 mmol) 
with Dess-Martin periodinane (34.4 mg, 0.081 mmol) and preparative thin layer chromatography 
(20% EtOAc/toluene) afforded 26 (6.8 mg, 93%). 
Following the procedure described above for 26, the oxidation of diol 25' (8.8 mg, 0.024 mmol) 
with Dess-Martin periodinane (40.8 mg, 0.096 mmol) and preparative thin layer chromatography 
(20% EtOAc/toluene) afforded 26 (7.3 mg, 84%). 
(R)-5'-(Methoxymethoxy)dispiro[cyclopentane-1,1'-cyclopentane-2',2''-naphtho[1,8-de][1,3]–
dioxine]-3,3'-diene-2,5-dione (27): To a stirred solution of cyclopentane-1,3-dione 26 (19.5 mg, 
0.0532 mmol) in anhydrous THF (0.5 mL) was added trimethylphenylammonium tribromide (22.1 
mg, 0.0588 mmol) at 0 °C. The reaction mixture was warmed to room temperature, stirred at the 
same temperature for 35 min, and treated with saturated aqueous NaHCO3 (2 mL) and 20% aqueous 
Na2S2O3·5H2O (2 mL). The immiscible mixture was extracted with ethyl acetate, washed with brine, 
dried over MgSO4, and concentrated. The residue was purified by preparative thin layer 
chromatography (20% EtOAc/toluene) to give 27 (9.2 mg, 47%) as a pale yellow amorphous mass 
along with 1 (5.3 mg, 31%) as a pale yellow amorphous mass. Rf 0.55 (33% Et2O/toluene). [α]D23.3 –
 25 
296 (c 0.46, CHCl3). IR ν (neat, cm-1): 2929, 1710, 1608, 1412, 1379, 1274, 1108, 1041, 757. 1H 
NMR (400 MHz, CDCl3): δ 7.46–7.33 (m, 4H), 7.23 (d, J = 6.1 Hz, 1H), 7.09 (d, J = 6.1 Hz, 1H), 
6.90 (d, J = 7.3 Hz, 1H), 6.83 (d, J = 7.5 Hz, 1H), 6.47 (dd, J = 1.6, 5.9 Hz, 1H), 5.97 (dd, J = 2.1, 
5.9 Hz, 1H), 5.30 (dd, J = 1.6, 2.1 Hz, 1H), 4.59 (d, J = 6.8 Hz, 1H), 4.57 (d, J = 6.8 Hz, 1H), 3.19 (s, 
3H). 13C NMR (100 MHz, CDCl3): δ 198.2, 195.5, 150.1, 149.7, 147.5, 147.2, 139.4, 134.2, 128.7, 
127.6, 127.3, 121.2, 120.8, 113.3, 109.8, 109.7, 109.5, 97.7, 83.6, 67.1, 55.8. HRMS (EI, [M]+): 
calcd for C21H16O6, 364.0947; found: 364.0952. 
Following the procedure described above for 26, the oxidation of diol 32a (8.0 mg, 0.019 mmol) 
with Dess-Martin periodinane (32.3 mg, 0.076 mmol) gave crude diketone 33a. After analysis of 33a, 
the crude was purified by preparative thin layer chromatography (20% EtOAc/toluene, left on a 
silica gel plate for 4 h after development) to give 27 (5.3 mg, 78%). 
33a as a pale yellow oil: Rf 0.67 (40% EtOAc/toluene). [α]D22.0 –159 (c 0.48, CHCl3). IR ν 
(compression cell, cm-1): 2972, 2929, 1737, 1608, 1380, 1276, 1103, 1041, 758. 1H NMR (400 MHz, 
CDCl3): δ 7.48–7.45 (m, 2H), 7.42–7.35 (m, 2H), 6.94 (dd, J = 0.9, 7.5 Hz, 1H), 6.88 (dd, J = 0.9, 
7.5 Hz, 1H), 6.37 (dd, J = 1.7, 5.9 Hz, 1H), 5.83 (dd, J = 2.2, 5.9 Hz, 1H), 5.22 (dd, J = 1.7, 2.2 Hz, 
1H), 4.63 (d, J = 6.6 Hz, 1H), 4.58 (d, J = 6.6 Hz, 1H), 4.15 (dd, J = 4.1, 7.5 Hz, 1H), 3.83 (qq, J = 
6.0, 6.2 Hz, 1H), 3.24 (s, 3H), 2.91 (dd, J = 7.5, 19.0 Hz, 1H), 2.82 (dd, J = 4.1, 19.0 Hz, 1H), 1.05 
(d, J = 6.0 Hz, 3H), 0.68 (d, J = 6.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 205.7, 202.3, 147.03, 
147.00, 138.6, 134.1, 127.6, 127.33, 127.30, 120.9, 120.8, 113.2, 110.6, 109.6, 109.3, 98.3, 85.2, 
75.0, 70.6, 70.4, 55.8, 46.3, 22.1, 20.7. LRMS (EI) m/z (relative intensity): 424 [M]+ (100), 363 (39), 
249 (33). HRMS (EI, [M]+): calcd for C24H24O7, 424.1522; found 424.1512. 
Following the procedure described above for 26, the oxidation of diol 32b (7.2 mg, 0.017 mmol) 
with Dess-Martin periodinane  (30.0 mg, 0.071 mmol) gave crude diketone 33b. After analysis of 
33b, the crude was purified by preparative thin layer chromatography (20% EtOAc/toluene, left on a 
silica gel plate for 4 h after development) to give 27 (3.7 mg, 61%). 
33b as a pale yellow oil: Rf 0.71 (40% EtOAc/toluene). [α]D23.0 –149 (c 0.42, CHCl3). IR ν 
(compression cell, cm-1): 2928, 1738, 1609, 1379, 1274, 1101, 1047, 759. 1H NMR (400 MHz, 
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CDCl3): δ 7.53–7.48 (m, 2H), 7.43–7.38 (m, 2H), 6.93 (d, J = 7.2 Hz, 1H), 6.90 (d, J = 7.5 Hz, 1H), 
6.41 (dd, J = 1.7, 5.9 Hz, 1H), 5.77 (dd, J = 2.2, 5.9 Hz, 1H), 5.35 (dd, J = 1.7, 2.2 Hz, 1H), 4.63 (d, 
J = 7.0 Hz, 1H), 4.61 (d, J = 7.0 Hz, 1H), 4.45 (dd, J = 5.7, 9.7 Hz, 1H), 4.04 (qq, J = 6.1, 6.2 Hz, 
1H), 3.30 (s, 3H), 2.92 (dd, J = 9.7, 18.7 Hz, 1H), 2.57 (dd, J = 5.7, 18.7 Hz, 1H), 1.22 (d, J = 6.2 
Hz, 3H), 1.18 (d, J = 6.1 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 205.3, 202.4, 147.0, 146.9, 139.9, 
134.1, 127.6, 127.2, 126.3, 121.5, 121.0, 113.4, 110.5, 110.0, 109.6, 97.9, 82.4, 72.5, 72.2, 56.7, 
44.8, 22.5, 21.6. LRMS (EI) m/z (relative intensity): 424 [M]+ (46), 364 (100), 280 (76), 149 (61). 
HRMS (EI, [M]+): calcd for C24H24O7, 424.1522; found 424.1510. 
Following the procedure described above for 26, the oxidation of diol 32b' (7.5 mg, 0.018 mmol) 
with Dess-Martin periodinane  (30.6 mg, 0.071 mmol) gave crude diketone 33b. After analysis of 
33b, the crude was purified by preparative thin layer chromatography (20% EtOAc/toluene, left on a 
silica gel plate for 4 h after development) to give 27 (4.9 mg, 77%). 
5'-Hydroxydispiro[cyclopentane-1,1'-cyclopentane-2',2''-naphtho[1,8-de][1,3]dioxine]-3,3'-
diene-2,5-dione (Spiromamakone A, 1): Following the procedure described above for 21a, the acid 
hydrolysis of 27 (8.6 mg, 0.024 mmol) gave crude spiromamakone A (1). After measurement of the 
specific rotation of 1, the crude was purified by preparative thin layer chromatography (25% 
EtOAc/toluene) to give 1 (5.7 mg, 75%) as a pale yellow amorphous mass. Rf 0.32 (25% 
EtOAc/toluene). [α]D27.3 –43.5 (c 0.38, CHCl3) and [α]D25.2 –1.2 (c 0.29, CHCl3) before and after 
preparative thin layer chromatography, respectively. IR ν (neat, cm-1): 3444, 2923, 2852, 1705, 1608, 
1412, 1273, 1105, 1076, 757. HRMS (EI, [M]+): calcd for C19H12O5, 320.0685; found 320.0698.  
1H NMR (400 MHz, CD3OD): δ 7.37 (d, J = 7.7 Hz, 1H), 7.35 (d, J = 7.7 Hz, 1H), 7.30 (dd, J = 
7.6, 7.7 Hz, 1H), 7.26 (dd, J = 7.6, 7.7 Hz, 1H), 7.12 (d, J = 6.1 Hz, 1H), 6.99 (d, J = 6.1 Hz, 1H), 
6.73 (d, J = 7.6 Hz, 1H), 6.66 (d, J = 7.6 Hz, 1H), 6.30 (dd, J = 1.7, 5.8 Hz, 1H), 5.83 (dd, J = 2.0, 
5.8 Hz, 1H), 5.20 (dd, J = 1.7, 2.0 Hz, 1H). 13C NMR (100 MHz, CD3OD): δ 200.8, 198.3, 151.9, 
151.6, 149.1, 148.5, 142.4, 135.7, 129.7, 128.7, 128.4, 122.2, 121.7, 114.5, 111.4, 110.7, 110.3, 78.9, 
68.6.  
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1H NMR (400 MHz, CDCl3): δ 7.46 (d, J = 8.4 Hz, 1H), 7.45 (d, J = 8.4 Hz, 1H), 7.39 (dd, J = 7.6, 
8.4 Hz, 1H), 7.37 (dd, J = 7.6, 8.4 Hz, 1H), 7.19 (d, J = 6.1 Hz, 1H), 7.13 (d, J = 6.1 Hz, 1H), 6.88 
(d, 1H, J = 7.6 Hz), 6.85 (d, 1H, J = 7.6 Hz), 6.41 (dd, J = 1.9, 5.8 Hz, 1H), 6.00 (dd, J = 1.6, 5.8 Hz, 
1H), 5.37 (d, J = 11.6 Hz, 1H), 2.66 (d, J = 11.6 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 198.5, 
197.6, 150.8, 150.2, 147.2, 146.9, 140.8, 134.1, 129.6, 127.6, 127.3, 121.2, 120.9, 113.3, 110.1, 
110.0, 109.6, 77.8, 66.8. 
(R)- and (S)- 2,5-Dioxodispiro[cyclopentane-1,1'-cyclopentane-2',2''-naphtho[1,8-de][1,3]–
dioxine]-3,3'-dien-5'-yl (R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate (28a and 28b): To a 
stirred solution of alcohol 1 (9.1 mg, 0.028 mmol) and (R)-MTPA-OH (10.7 mg, 0.046 mmol) in 
anhydrous CH2Cl2 (0.3 mL) were successively added EDCI (10.9 mg, 0.057 mmol) and DMAP (1.2 
mg, 9.8 µmmol) at room temperature. After being stirred at the same temperature for 1.5 h, the 
reaction mixture was treated with (R)-MTPA-OH (4.5 mg, 0.019 mmol) and EDCI (5.6 mg, 0.029 
mmol) and stirred for another 2 h. Again, (R)-MTPA-OH (6.4 mg, 0.027 mmol) was added to the 
mixture. The mixture was stirred for another 2 h and treated with additional small amounts of (R)-
MTPA-OH, EDCI, and DMAP to complete the consumption of 1. After being stirred for another 3 h, 
the resulting mixture was diluted with Et2O, washed with 1 M aqueous HCl, H2O, saturated aqueous 
NaHCO3, and brine successively, dried over MgSO4, and concentrated. The residue was purified by 
preparative thin layer chromatography (toluene only, developed 10 times) to give (R)-2,5-
dioxodispiro[cyclopentane-1,1'-cyclopentane-2',2''-naphtho[1,8-de][1,3]dioxine]-3,3'-dien-5'-yl (R)-
3,3,3-trifluoro-2-methoxy-2-phenylpropanoate 28a (8.0 mg, 53%) and (S)-2,5-
dioxodispiro[cyclopentane-1,1'-cyclopentane-2',2''-naphtho[1,8-de][1,3]dioxine]-3,3'-dien-5'-yl (R)-
3,3,3-trifluoro-2-methoxy-2-phenylpropanoate 28b (4.8 mg, 32%) as a faster- and slower-moving 
component, respectively. 
(R)-2,5-Dioxodispiro[cyclopentane-1,1'-cyclopentane-2',2''-naphtho[1,8-de][1,3]dioxine]-3,3'-
dien-5'-yl (R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate (28a, upper and major component) 
as a yellow waxy solid: Rf 0.73 (25% EtOAc/toluene). [α]D25.4 –148 (c 0.090, CHCl3). IR ν 
(compression cell, cm-1): 2927, 1748, 1714, 1269, 1195, 1037, 758. 1H NMR (400 MHz, CDCl3): δ 
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7.48–7.35 (m, 8H), 7.16 (d, J = 6.1 Hz, 1H), 7.11 (d, J = 6.1 Hz, 1H), 6.91 (dd, J = 0.9, 7.5 Hz, 1H), 
6.85 (d, J = 7.5 Hz, 1H), 6.39 (dd, J = 1.9, 5.9 Hz, 1H), 6.15 (dd, J = 1.7, 5.9 Hz, 1H), 6.07 (dd, J = 
1.7, 1.9 Hz, 1H), 3.56 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 196.5, 194.1, 166.9, 149.54, 149,49, 
146.9, 146.7, 135.6, 134.1, 132.2, 131.4, 129.8, 128.5, 127.6, 127.35, 127.32 (q, J = 1.2 Hz), 122.9 
(q, J = 289 Hz), 121.3, 121.1, 113.2, 110.0, 109.9, 109.8, 84.3 (q, J = 27.8 Hz), 80.4, 64.8, 55.7 (q, J 
= 1.4 Hz). LRMS (EI) m/z (relative intensity): 536 [M]+ (68), 303 (30), 189 (100). HRMS (EI, 
[M]+): calcd for C29H19F3O7, 536.1083; found 536.1081. 
(S)-2,5-Dioxodispiro[cyclopentane-1,1'-cyclopentane-2',2''-naphtho[1,8-de][1,3]dioxine]-3,3'-
dien-5'-yl (R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate (28b, lower and minor component) 
as a yellow waxy solid: Rf 0.73 (25% EtOAc/toluene). [α]D24.3 +196 (c 0.24, CHCl3). IR ν 
(compression cell, cm-1): 2926, 1749, 1714, 1273, 1195, 1056, 758. 1H NMR (400 MHz, CDCl3): δ 
7.48–7.33 (m, 8H), 7.08 (d, J = 6.1 Hz, 1H), 7.05 (d, J = 6.1 Hz, 1H), 6.92 (d, J = 7.4 Hz, 1H), 6.82 
(d, J = 7.5 Hz, 1H), 6.49 (dd, J = 1.8, 5.9 Hz, 1H), 6.24 (dd, J = 1.8, 1.8 Hz, 1H), 6.16 (dd, J = 1.8, 
5.9 Hz, 1H), 3.51 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 196.4, 193.8, 166.3, 149.6, 149.5, 147.0, 
146.7, 135.6, 134.1, 132.2, 131.4, 129.7, 128.5, 127.7, 127.30, 127.28, 122.9 (q, J = 288 Hz), 121.5, 
121.4, 121.1, 113.1, 110.0, 109.7, 109.5, 84.4 (q, J = 27.8 Hz), 79.7, 64.8, 55.5 (q, J = 1.3 Hz). 
LRMS (EI) m/z (relative intensity): 536 [M]+ (59), 303 (30), 189 (100), 149 (36). HRMS (EI, [M]+): 
calcd for C29H19F3O7, 536.1083; found 536.1035. 
(1R,5R,5'R)-5-Hydroxy-5'-(methoxymethoxy)dispiro[cyclopentane-1,1'-cyclopentane-2',2''-
naphtho[1,8-de][1,3]dioxine]-2,3'-dien-4-one (30): To a stirred suspension of lithium aluminum 
hydride (30.1 mg, 0.793 mmol) in anhydrous THF (0.4 mL) was added a solution of allyl alcohol 
22b (170 mg, 0.401 mmol) in anhydrous THF (4 mL) at 0 °C. The reaction mixture was allowed to 
warm to room temperature over 1 h, cooled to 0 °C again, and treated with saturated aqueous 
Na2SO4·10H2O (151 µL). The resulting mixture was stirred at room temperature for 1 h, dried over 
MgSO4, diluted with EtOAc, and filtered through a Celite pad, which was thoroughly rinsed with 
EtOAc. The filtrate was concentrated to give a crude alcohol 29 (154 mg, 90%), which was used for 
the next reaction without further purification. 
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To a stirred solution of the crude alcohol 29 (154 mg) in anhydrous THF (3.6 mL) was added 1 M 
aqueous HCl (1.2 mL, 1.2 mmol) at room temperature. After being stirred at the same temperature 
for 2 h, the reaction mixture was basified with saturated aqueous NaHCO3 (4 mL). The resulting 
mixture was extracted with EtOAc, washed with brine, dried over MgSO4, and concentrated. The 
residue was purified by preparative thin layer chromatography (33% EtOAc/toluene) and then HPLC 
(column size: 8ø x 300 mm, eluent: 20% i-PrOH/hexane, flow rate: 1 mL/min, RT: 23–25 min) to 
give 30 (75.0 mg, 51% from 22b over 2 steps) as a white solid. Rf 0.19 (25% EtOAc/toluene). Mp. 
151–153 °C. [α]D17.2 –341 (c 0.670, CHCl3). IR ν (compression cell, cm-1): 3570, 2946, 1731, 1611, 
1414, 1271, 1146, 1116, 959, 813. 1H NMR (400 MHz, CDCl3): δ 7.71 (d, J = 6.4 Hz, 1H), 7.51–
7.46 (m, 2H), 7.41–7.36 (m, 2H), 6.90 (d, J = 7.5 Hz, 1H), 6.82 (d, J = 7.5 Hz, 1H), 6.43 (d, J = 6.4 
Hz, 1H), 6.40 (dd, J = 1.5, 6.2 Hz, 1H), 6.03 (dd, J = 2.3, 6.2 Hz, 1H), 5.21 (dd, J = 1.5, 2.3 Hz, 1H), 
4.86 (d, J = 11.1 Hz, 1H), 4.84 (d, J = 6.9 Hz, 1H), 4.76 (d, J = 6.9 Hz, 1H), 3.39 (s, 3H), 3.09 (d, J 
= 11.1 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 204.9, 158.0, 147.2, 146.6, 139.7, 134.2, 133.8, 
129.3, 127.33, 127.28, 121.5, 120.9, 113.5, 111.3, 109.6, 109.1, 96.7, 81.8, 75.9, 66.0, 55.8. LRMS 
(EI) m/z (relative intensity): 366 [M]+ (81), 304 (100), 275 (52), 133 (58). HRMS (EI, [M]+): calcd 
for C21H18O6, 366.1103; found 366.1082.  
(1S,5R,5'R)-5'-(Methoxymethoxy)-4-oxodispiro[cyclopentane-1,1'-cyclopentane-2',2''-
naphtho[1,8-de][1,3]dioxine]-2,3'-dien-5-yl acetate (31): Following the procedure described above 
for 23a, the acetylation of 30 (11.2 mg, 0.0306 mmol) and preparative thin layer chromatography 
(20% EtOAc/toluene) afforded 31 (12.8 mg, quant.) as a white amorphous mass. Rf 0.55 (40% 
EtOAc/toluene). [α]D21.0 –322 (c 0.640, CHCl3). IR ν (compression cell, cm-1): 2934, 1752, 1735, 
1608, 1379, 1230, 1115, 1056, 759. 1H NMR (400 MHz, CDCl3): δ 7.73 (d, J = 6.4 Hz, 1H), 7.48–
7.44 (m, 2H), 7.42–7.35 (m, 2H), 6.94 (d, J = 7.5 Hz, 1H), 6.80 (d, J = 7.4 Hz, 1H), 6.38 (d, J = 6.4 
Hz, 1H), 6.24 (dd, J = 1.4, 6.2 Hz, 1H), 6.14 (s, 1H), 6.01 (dd, J = 2.3, 6.2 Hz, 1H), 5.21 (dd, J = 1.4, 
2.3 Hz, 1H), 4.83 (d, J = 6.9 Hz, 1H), 4.77 (d, J = 6.9 Hz, 1H), 3.39 (s, 3H), 2.14 (s, 3H). 13C NMR 
(100 MHz, CDCl3): δ 199.9, 169.8, 158.4, 147.8, 147.5, 138.5, 134.2, 130.3, 127.5, 127.2, 120.9, 
120.7, 113.9, 109.7, 109.6, 108.7, 96.9, 81.6, 72.7, 66.2, 55.9, 21.0. LRMS (EI) m/z (relative 
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intensity): 408 [M]+ (62), 304 (100), 275 (38), 247 (37), 225 (31). HRMS (EI, [M]+): calcd for 
C23H20O7, 408.1209; found 408.1190.  
(1S,2R,5S,5'R)-3-Isopropoxy-5'-(methoxymethoxy)dispiro[cyclopentane-1,1'-cyclopentane-
2',2''-naphtho[1,8-de][1,3]dioxin]-3'-ene-2,5-diol (32a) and (2S,5S,5'R)-5'-
(methoxymethoxy)dispiro[cyclopentane-1,1'-cyclopentane-2',2''-naphtho[1,8-de][1,3]dioxin]-
3'-ene-2,5-diol (25): To a stirred solution of alcohol 22a (10.4 mg, 0.0245 mmol) in anhydrous THF 
(0.5 mL) was added 2.0 M lithium borohydride solution in THF (0.075 mL, 0.15 mmol) at 0 °C. The 
reaction mixture was allowed to warm to room temperature over 15 h and treated with saturated 
aqueous NH4Cl (3 mL). The immiscible mixture was stirred for another 1 h, extracted with EtOAc, 
washed with brine, dried over MgSO4, and concentrated. The residue was purified by preparative 
thin layer chromatography (50% EtOAc/hexane) to give pure 32a (6.3 mg, 60%) and impure 25 (1.6 
mg) as a faster- and slower-moving component, respectively. The latter was further purified by 
preparative thin layer chromatography (20% acetone/toluene) to give pure 25 (1.5 mg, 17%).  
32a as a white amorphous mass: Rf 0.48 (60% EtOAc/hexane), 0.25 (30% acetone/hexane), 0.39 
(40% EtOAc/toluene) and 0.40 (20% acetone/toluene). [α]D21.0 +7.7 (c 1.30, CHCl3). IR ν 
(compression cell, cm-1): 3569, 3450, 2970, 1608, 1380, 1275, 1148, 1037, 758. 1H NMR (400 MHz, 
CDCl3): δ 7.52–7.49 (m, 2H), 7.43–7.39 (m, 2H), 6.96 (d, J = 7.5 Hz, 1H), 6.88 (d, J = 7.5 Hz, 1H), 
6.33 (dd, J = 2.5, 6.1 Hz, 1H), 5.98 (d, J = 6.1 Hz, 1H), 5.16 (dd, J = 3.8, 6.8 Hz, 1H), 4.77–4.72 (m, 
3H), 4.67 (d, J = 2.5 Hz, 1H), 4.02–3.97 (m, 1H), 3.82 (qq, J = 6.1, 6.2 Hz, 1H), 3.40 (s, 3H), 2.91 
(br-s, 1H), 2.48–2.41 (m, 1H), 2.00–1.98 (m, 1H), 1.83 (dd, J = 2.8, 14.5 Hz, 1H), 1.25 (d, J = 6.1 
Hz, 3H), 1.23 (d, J = 6.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 147.9, 147.4, 139.3, 134.3, 130.7, 
127.4, 127.2, 121.2, 120.9, 113.9, 111.7, 109.7, 109.5, 96.7, 81.5, 79.8, 78.8, 71.5, 70.8, 62.0, 55.7, 
37.0, 23.0, 22.3. LRMS (EI) m/z (relative intensity): 428 [M]+ (6), 410 (65), 251 (100), 149 (37). 
HRMS (EI, [M]+): calcd for C24H28O7, 428.1835; found 428.1852. 
(1R,2R,5S,5'R)-3-Isopropoxy-5'-(methoxymethoxy)dispiro[cyclopentane-1,1'-cyclopentane-
2',2''-naphtho[1,8-de][1,3]dioxin]-3'-en-2,5-diyl diacetate (Diacetate of 32a): Following the 
procedure described above for 23a, the acetylation of 32a (2.6 mg, 0.0061 mmol) with  triethylamine 
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(9+4 µL, 0.094 mmol) and acetic anhydride (4+2 µL, 0.063 mmol) and preparative thin layer 
chromatography (33% EtOAc/toluene) afforded diacetate of 32a (2.8 mg, 90%) as a white 
amorphous mass. Rf 0.57 (40% EtOAc/toluene). [α]D17.6 +66 (c 0.37, CHCl3). IR ν (neat, cm-1): 2971, 
2930, 1739, 1608, 1380, 1236, 1150, 1041, 758. 1H NMR (400 MHz, CDCl3): δ 7.46–7.34 (m, 4H), 
6.88 (d, J = 7.4 Hz, 1H), 6.85 (d, J = 7.4 Hz, 1H), 6.38 (d, J = 6.2 Hz, 1H), 6.26 (dd, J = 2.8, 6.1 Hz, 
1H), 5.95 (d, J = 6.1 Hz, 1H), 5.77 (d, J = 5.0 Hz, 1H), 4.81 (d, J = 7.0 Hz, 1H), 4.75 (d, J = 7.0 Hz, 
1H), 4.60 (d, J = 2.8 Hz, 1H), 4.12–4.08 (m, 1H), 3.63 (qq, J = 6.1, 6.1 Hz, 1H), 3.41 (s, 3H), 2.60–
2.52 (m, 1H), 2.02 (s, 3H), 1.82 (dd, J = 3.3, 15.4 Hz, 1H), 1.71 (s, 3H), 1.16 (d, J = 6.1 Hz, 3H), 
1.15 (d, J = 6.1 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 170.6, 168.6, 148.0, 147.7, 136.5, 134.1, 
132.4, 127.34, 127.33, 120.3, 120.0, 113.3, 109.2, 109.1, 108.8, 96.3, 81.4, 79.55, 79.51, 73.1, 71.1, 
61.4, 55.8, 36.6, 22.39, 22.37, 21.61, 21.13. LRMS (EI) m/z (relative intensity): 512 [M]+ (100), 306 
(56), 305 (62). HRMS (EI, [M]+): calcd for C28H32O9, 512.2046; found 512.2020.  
(1R,2R,5R,5'R)- and (1R,2R,5S,5'R)-3-Isopropoxy-5'-(methoxymethoxy)dispiro[cyclopent–
ane-1,1'-cyclopentane-2',2''-naphtho[1,8-de][1,3]dioxin]-3'-ene-2,5-diols (32b and 32b') and 
(2S,5S,5'R)- and (1s,2R,5S,5'R)-5'-(methoxymethoxy)dispiro[cyclopentane-1,1'-cyclopentane-
2',2''-naphtho[1,8-de][1,3]dioxin]-3'-ene-2,5-diol (25, 25'): Following the procedure described 
above for 32a and 25, the reduction of 22b (100 mg, 0.236 mmol) gave a mixture containing 32b, 
32b', 25, and 25'. The products were purified by preparative thin layer chromatography (17% 
EtOAc/toluene, developed 4 times) to give two mixtures of 32b+25' and 32b'+25 as a faster- and 
slower-moving component, respectively. Further purification of the former mixture with preparative 
thin layer chromatography (30% acetone/hexane, developed 2 times) afforded pure 32b (31.6 mg, 
31%) and impure 25' (9.6 mg) as a faster- and slower-moving component, respectively. Pure 25' (3.9 
mg, 7%) was obtained by further purification with preparative thin layer chromatography (60% 
EtOAc/hexane, developed 3 times). Further purification of the latter mixture with preparative thin 
layer chromatography (30% acetone/hexane, developed 2 times) afforded pure 32b' (19.9 mg, 20%) 
and impure 25 (5.6 mg) as a faster- and slower-moving component, respectively. Pure 25 (3.9 mg, 
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4%) was obtained by further purification with preparative thin layer chromatography (60% 
EtOAc/hexane, developed 3 times). 
32b as a white amorphous mass: 0.33 (40% EtOAc/toluene). [α]D20.3 –137 (c 0.650, CHCl3). IR ν 
(compression cell, cm-1): 3563, 2970, 1608, 1413, 1380, 1273, 1038. 1H NMR (400 MHz, CDCl3): δ 
7.57–7.54 (m, 2H), 7.48–7.41 (m, 2H), 7.01 (d, J = 7.5 Hz, 1H), 6.90 (d, J = 7.5 Hz, 1H), 6.40 (dd, J 
= 1.8, 6.2 Hz, 1H), 5.88 (dd, J = 1.4, 6.2 Hz, 1H), 4.94 (br-s, 1H), 4.85 (d, J = 7.1 Hz, 1H), 4.83 (d, J 
= 7.1 Hz, 1H), 4.43 (dd, J = 5.5, 10.2 Hz, 1H), 4.33–4.26 (m, 2H), 3.95 (d, J = 9.8 Hz, 1H), 3.84 (qq, 
J = 6.1, 6.1 Hz, 1H), 3.44 (s, 3H), 2.87 (d, J = 10.2 Hz, 1H), 2.39 (ddd, J = 9.7, 9.7, 13.5 Hz, 1H), 
2.07 (ddd, J = 2.7, 7.0, 13.5 Hz, 1H), 1.22 (d, J = 6.1 Hz, 3H), 1.20 (d, J = 6.1 Hz, 3H). 13C NMR 
(100 MHz, CDCl3): δ 146.8, 146.6, 140.9, 134.3, 128.5, 127.39, 127.37, 121.5, 121.4, 113.9, 113.8, 
109.8, 109.7, 97.3, 81.4, 81.1, 79.4, 73.4, 70.5, 63.0, 55.7, 39.1, 22.7, 22.4. LRMS (EI) m/z (relative 
intensity): 428 [M]+ (14), 410 (100), 251 (65). HRMS (EI, [M]+): calcd for C24H28O7, 428.1835; 
found 428.1836. 
32b' as a white amorphous mass: 0.30 (40% EtOAc/toluene). [α]D20.5 –9.5 (c 0.37, CH3OH). IR ν 
(compression cell, cm-1): 3573, 3438, 2969, 1607, 1380, 1274, 1096, 1038. 1H NMR (400 MHz, 
CDCl3): δ 7.54–7.50 (m, 2H), 7.45–7.40 (m, 2H), 6.99 (d, J = 7.3 Hz, 1H), 6.90 (d, J = 7.0 Hz, 1H), 
6.35 (dd, J = 2.4, 6.0 Hz, 1H), 5.92 (d, J = 6.0 Hz, 1H), 5.00 (dd, J = 7.6, 12.0 Hz, 1H), 4.94 (d, J = 
6.9 Hz, 1H), 4.83 (d, J = 2.4 Hz, 1H), 4.80 (dd, J = 2.8, 5.5 Hz, 1H), 4.74 (d, J = 6.9 Hz, 1H), 4.03–
3.99 (m, 1H), 3.83 (qq, J = 6.1, 6.2 Hz, 1H), 3.41 (s, 3H), 2.93 (d, J = 5.5 Hz, 1H), 2.65 (ddd, J = 7.3, 
7.6, 13.7 Hz, 1H), 1.94 (br-s, 1H), 1.73 (ddd, J = 5.5, 8.2, 13.7 Hz, 1H), 1.21 (d, J = 6.2 Hz, 3H), 
1.19 (d, J = 6.1 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 147.9, 147.3, 140.9, 134.3, 129.2, 127.4, 
127.3, 121.3, 120.9, 114.0, 111.9, 109.65, 109.57, 97.5, 81.6, 80.5, 78.7, 72.2, 70.2, 63.7, 55.6, 38.0, 
22.9, 22.1. LRMS (EI) m/z (relative intensity): 428 [M]+ (20), 410 (100), 251 (36). HRMS (EI, 
[M]+): calcd for C24H28O7, 428.1835; found 428.1846. 
25' as a white amorphous mass: 0.27 (30% acetone/hexane) and 0.30 (40% EtOAc/toluene). 
[α]D19.3 –61 (c 0.44, CHCl3). IR ν (compression cell, cm-1): 3548, 2948, 1608, 1413, 1381, 1276, 
1041, 758. 1H NMR (400 MHz, CDCl3): δ 7.54–7.51 (m, 2H), 7.45–7.40 (m, 2H), 6.99 (dd, J = 0.8, 
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7.5 Hz, 1H), 6.92 (dd, J = 0.7, 7.5 Hz, 1H), 6.31 (dd, J = 2.3, 6.1 Hz, 1H), 6.01 (dd, J = 0.7, 6.1 Hz, 
1H), 4.78 (d, J = 6.9 Hz, 1H), 4.74–4.70 (m, 1H), 4.71 (d, J = 6.9 Hz, 1H), 4.35 (dd, J = 0.7, 2.3 Hz, 
1H), 4.27–4.22 (m, 2H), 3.40 (s, 3H), 3.37 (d, J = 9.1 Hz, 1H), 2.26–2.12 (m, 4H). 13C NMR (100 
MHz, CDCl3): δ 147.3, 147.0, 138.5, 134.3, 130.7, 127.4, 127.2, 121.3, 121.0, 114.0, 113.6, 109.8, 
109.5, 96.8, 83.3, 77.9, 74.2, 63.3, 55.7, 31.5, 31.4. LRMS (EI) m/z (relative intensity): 370 [M]+ 
(12), 352 (100), 291 (25), 160 (37). HRMS (EI, [M]+): calcd for C21H22O6, 370.1416; found 
370.1413. 
(1S,2R,5R,5'R)-3-Isopropoxy-5'-(methoxymethoxy)dispiro[cyclopentane-1,1'-cyclopentane-
2',2''-naphtho[1,8-de][1,3]dioxin]-3'-en-2,5-diyl diacetate (Diacetate of 32b): Following the 
procedure described above for 23a, the acetylation of 32b (6.2 mg, 0.014 mmol) with  triethylamine 
(20 µL, 0.14 mmol) and acetic anhydride (8 µL, 0.085 mmol) and preparative thin layer 
chromatography (25% EtOAc/toluene) afforded diacetate of 32b (6.4 mg, 86%) as a white solid. Rf 
0.67 (40% EtOAc/toluene). Mp. 169–171 °C. [α]D24.7 –18 (c 0.32, CHCl3). IR ν (compression cell, 
cm-1): 2969, 1733, 1381, 1236, 1034, 994. 1H NMR (400 MHz, CDCl3): δ 7.47–7.44 (m, 2H), 7.42–
7.36 (m, 2H), 6.91 (d, J = 7.3 Hz, 1H), 6.77 (d, J = 7.4 Hz, 1H), 6.19 (dd, J = 1.2, 6.1 Hz, 1H), 5.98 
(d, J = 3.3 Hz, 1H), 5.90 (d, J = 6.1 Hz, 1H), 5.60 (d, J = 2.9 Hz, 1H), 4.85 (d, J = 7.0 Hz, 1H), 4.78 
(d, J = 7.0 Hz, 1H), 4.49 (br-s, 1H), 4.37–4.33 (m, 1H), 3.87 (qq, J = 6.0, 6.1 Hz, 1H), 3.38 (s, 3H), 
2.37–2.31 (m, 1H), 2.11–2.07 (m, 1H), 2.05 (s, 3H), 1.86 (s, 3H), 1.19 (d, J = 6.1 Hz, 3H), 1.15 (d, J 
= 6.0 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 170.4, 169.8, 148.1, 147.9, 137.3, 134.3, 131.7, 127.4, 
127.3, 120.34, 120.26, 113.8, 110.3, 108.9, 108.7, 97.2, 84.4, 81.0, 75.2, 70.7, 63.4, 55.5, 38.3, 22.9, 
21.7, 21.5, 21.3. LRMS (EI) m/z (relative intensity): 512 [M]+ (100), 306 (79), 160 (51). HRMS (EI, 
[M]+): calcd for C28H32O9, 512.2046; found 512.2036. 
(1S,2R,5S,5'R)-3-Isopropoxy-5'-(methoxymethoxy)dispiro[cyclopentane-1,1'-cyclopentane-
2',2''-naphtho[1,8-de][1,3]dioxin]-3'-en-2,5-diyl diacetate (Diacetate of 32b'): Following the 
procedure described above for 23a, the acetylation of 32b' (6.0 mg, 0.014 mmol) with  triethylamine 
(20 µL, 0.14 mmol) and acetic anhydride (8 µL, 0.085 mmol) and preparative thin layer 
chromatography (25% EtOAc/toluene) afforded diacetate of 32b' (7.0 mg, 97%) as a white 
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amorphous mass. Rf 0.73 (40% EtOAc/toluene). [α]D21.4 +96 (c 0.35, CHCl3). IR ν (compression cell, 
cm-1): 2971, 2930, 1743, 1608, 1381, 1231, 1037, 758. 1H NMR (400 MHz, CDCl3): δ 7.47–7.43 (m, 
2H), 7.40–7.36 (m, 2H), 6.89 (d, J = 7.4 Hz, 1H), 6.85 (d, J = 7.5 Hz, 1H), 6.27 (dd, J = 2.7, 6.1 Hz, 
1H), 6.06 (dd, J = 8.3, 8.5 Hz, 1H), 5.93 (br-s, 1H), 5.87 (d, J = 6.1 Hz, 1H), 4.92 (d, J = 6.9 Hz, 1H), 
4.74 (d, J = 6.9 Hz, 1H), 4.65 (d, J = 2.7 Hz, 1H), 3.90–3.83 (m, 2H), 3.66 (s, 3H), 2.89 (ddd, J = 8.2, 
8.3, 14.3 Hz, 1H), 2.01 (s, 3H), 1.74–1.67 (m, 1H), 1.70 (s, 3H), 1.19 (d, J = 6.2 Hz, 3H), 1.13 (d, J 
= 6.0 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 169.9, 169.8, 148.1, 147.9, 138.8, 134.2, 130.4, 127.4, 
127.3, 120.4, 120.1, 113.5, 111.0, 109.0, 108.9, 97.6, 82.0, 78.8, 76.9, 73.2, 70.7, 61.6, 55.4, 36.7, 
22.8, 21.7, 21.1, 20.9. LRMS (EI) m/z (relative intensity): 512 [M]+ (100), 408 (41), 306 (66), 160 
(41). HRMS (EI, [M]+): calcd for C28H32O9, 512.2046; found 512.2020. 
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